Susanna Proudman

Susanna Proudman

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Dr Susanna Proudman graduated from Adelaide University in 1987 and trained in rheumatology at the Royal Adelaide Hospital where she is now Rheumatology Unit Director. As an ARA Michael Mason Fellow, she trained with Professor Paul Emery in Leeds, establishing one of the first Early Arthritis Clinics in the world.

Recent research interests include “best practice” management of early rheumatoid arthritis with an emphasis on “treat-to-target” therapy, the role of omega-3 fatty acids and periodontal disease and standardized management of systemic sclerosis and pulmonary arterial hypertension. In establishing a “Centre of Excellence” for the treatment of PAH in SSc and as Chair of the Australian Scleroderma Interest Group, she established the Australian Scleroderma Cohort Study in 2007 with collaborations such as the International Systemic Sclerosis Inception Cohort (INSYNC) and the Scleroderma Clinical Trials Consortium Damage Index working group. She is Medical Director of Arthritis Australia and Chair of the Actelion Clinical Excellence Program.

My Research

Susanna Proudman graduated from Adelaide University in 1987 and trained in rheumatology at the Royal Adelaide Hospital where she is now Rheumatology Unit Director. As an ARA Michael Mason Fellow, she trained with Professor Paul Emery in Leeds, establishing one of the first Early Arthritis Clinics in the world.

Recent research interests include “best practice” management of early rheumatoid arthritis with an emphasis on “treat-to-target” therapy, the role of omega-3 fatty acids and periodontal disease and standardized management of systemic sclerosis and pulmonary arterial hypertension.  In establishing a “Centre of Excellence” for the treatment of PAH in SSc and as Chair of the Australian Scleroderma Interest Group, she established the Australian Scleroderma Cohort Study in 2007 with collaborations such as the International Systemic Sclerosis Inception Cohort (INSYNC) and the Scleroderma Clinical Trials Consortium Damage Index working group. She is Medical Director of Arthritis Australia and Chair of the Actelion Clinical Excellence Program.

    Expand

  • Appointments
    Date Position Institution name
    2016 Head of Unit Royal Adelaide Hospital, Adelaide
    2012 - 2014 Clinical lead Central Adelaide Local Health Network
    2011 Clinical Associate Professor University of Adelaide
    2011 - 2015 Research Scientist - Grade 5 Royal Adelaide Hospital, Adelaide
    1998 Senior Staff Specialist, Rheumatology Royal Adelaide Hospital

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2014 Award Taverner Award for best presentation — — —
    2013 Award State ARA award for best clinical presentation — — —
    2012 Award Award for Best Clinical Paper — — —

  • Education
    Date Institution name Country Title
    1994 Royal Australasian College of Physicians, Sydney Australia Fellow
    1990 Royal Australasian College of Physicians, Sydney Australia Part I; Fellowship Examination
    — University of Adelaide Australia MBBS (Hons)

  • Certifications
    Date Title Institution name Country
    2014 Fellow Royal Australasian College of Physicians —

  • Research Interests
    Cardiac, Respiratory and Vascular Health Musculoskeletal Health Immunology and Infection Innovative Therapeutics
    Expand

  • Journals
    Year Citation
    2021 Khadra, Y., Walker, J. G., Hakendorf, P., Proudman, S., Rischmueller, M., Hill, C. L., . . . Roberts-Thomson, P. J. (2021). Scleroderma renal crisis: observations from the South Australian Scleroderma Register. Internal Medicine Journal, 51(2), 235-242.
    DOI
    2021 Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2021). Clinical characteristics and survival in systemic sclerosis-mixed connective tissue disease and systemic sclerosis-overlap syndrome. Arthritis Care and Research, 73(5), 732-741.
    DOI Scopus1 WoS3 Europe PMC2
    2021 Wiese, M. D., Hopkins, A. M., King, C., Wechalekar, M. D., Lee, A., Spargo, L., . . . Proudman, S. M. (2021). Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis. Arthritis care & research, 73(7), 983-989.
    DOI Europe PMC1
    2021 Wu, Y., Kwakkenbos, L., Henry, R. S., Carrier, M. E., Gagarine, M., Harb, S., . . . Hebblethwaite, S. (2021). Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study. Journal of Psychosomatic Research, 140, 110314.
    DOI Scopus1
    2021 Richard, N., Gyger, G., Hoa, S., Proudman, S., Stevens, W., Nikpour, M., . . . Canadian Scleroderma Research Group (CSRG), Australian Scleroderma Interest Group (ASIG). (2021). Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosis.. Clinical and experimental rheumatology, 39(Suppl. 131), S-142-S-148.
    2021 Hoa, S., Bernatsky, S., Baron, M., Proudman, S., Stevens, W., Sahhar, J., . . . Hudson, M. (2021). Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis.. Chest.
    DOI
    2021 Adams, L., Lester, S., Hoon, E., van der Haak, H., Proudman, C., Hall, C., . . . Hill, C. L. (2021). Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia. Internal Medicine Journal, 51(7), 1028-1037.
    DOI
    2021 Jones, B., Flurey, C. A., Proudman, S., Ferreira, R. J. O., Voshaar, M., Hoogland, W., . . . Boers, M. (2021). Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report. Seminars in Arthritis and Rheumatism.
    DOI
    2021 Roofeh, D., Barratt, S. L., Wells, A. U., Kawano-Dourado, L., Tashkin, D., Strand, V., . . . Khanna, D. (2021). Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process.. Seminars in arthritis and rheumatism.
    DOI
    2021 Ghofrani, H. A., Gomez Sanchez, M. A., Humbert, M., Pittrow, D., Simonneau, G., Gall, H., . . . Schulz, C. (2021). Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry. Respiratory Medicine, 178, 106220.
    DOI Scopus3 Europe PMC1
    2021 Proudman, S. M., & Corte, T. J. (2021). Are serum biomarkers useful in the management of systemic sclerosis-associated interstitial lung disease?. Respirology, 26(5), 406-408.
    DOI
    2021 Sree Raman, K., Shah, R., Stokes, M., Walls, A., Woodman, R. J., Perry, R., . . . Selvanayagam, J. B. (2021). Right ventricular myocardial deoxygenation in patients with pulmonary artery hypertension. Journal of Cardiovascular Magnetic Resonance, 23(1), 22-1-22-11.
    DOI
    2021 Tran‐Duy, A., Morrisroe, K., Clarke, P., Stevens, W., Proudman, S., Sahhar, J., & Nikpour, M. (2021). Cost‐effectiveness of combination therapy for patients with systemic sclerosis–related pulmonary arterial hypertension. Journal of the American Heart Association, 10(7), e015816-1-e015816-[17].
    DOI Europe PMC1
    2021 Brown, Z., Proudman, S., Morrisroe, K., Stevens, W., Hansen, D., & Nikpour, M. (2021). Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: a systematic review and meta-analysis of long-term outcomes. Seminars in Arthritis and Rheumatism, 51(3), 495-512.
    DOI WoS1
    2021 Acosta-Herrera, M., Kerick, M., Lopéz-Isac, E., Assassi, S., Beretta, L., Simeón-Aznar, C. P., . . . Martin, J. (2021). Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes. Annals of the Rheumatic Diseases, 80(8), 1040-1047.
    DOI
    2021 Lee, A., Patterson, K. A., Tan, D. J., Wilson, M. E., Proudman, S. M., Stevens, W., . . . Walker, J. G. (2021). Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients. Scandinavian Journal of Rheumatology, 1-6.
    DOI Scopus1
    2021 Abuhelwa, A. Y., Foster, D. J. R., Manning-Bennett, A., Sorich, M. J., Proudman, S., Wiese, M. D., & Hopkins, A. M. (2021). Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis. Therapeutic Advances in Musculoskeletal Disease, 13, 7 pages.
    DOI
    2021 Maltez, N., Hughes, M., Brown, E., Hickey, V., Park, H., Shea, B., . . . Merkel, P. A. (2021). Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: Report from OMERACT 2020. Seminars in Arthritis and Rheumatism, 51(3), 640-643.
    DOI
    2020 Valenzuela, A., Baron, M., Rodriguez-Reyna, T. S., Proudman, S., Khanna, D., Young, A., . . . Chung, L. (2020). Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. Seminars in Arthritis and Rheumatism, 50(5), 891-896.
    DOI Scopus2 WoS2 Europe PMC1
    2020 Patel, S., Morrisroe, K., Proudman, S., Hansen, D., Sahhar, J., Sim, M. R., . . . Australian Scleroderma Interest Group. (2020). Occupational silica exposure in an Australian systemic sclerosis cohort. Rheumatology, 59(12), 3900-3905.
    DOI Scopus2 WoS2 Europe PMC1
    2020 Abuhelwa, A. Y., Hopkins, A. M., Sorich, M. J., Proudman, S., Foster, D. J. R., & Wiese, M. D. (2020). Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs. Scientific Reports, 10(1), 9 pages.
    DOI
    2020 Raman, K. S., Shah, R., Stokes, M., Walls, A., Woodman, R. J., Ananthakrishna, R., . . . Selvanayagam, J. B. (2020). Left ventricular ischemia in pre-capillary pulmonary hypertension: a cardiovascular magnetic resonance study. Cardiovascular Diagnosis and Therapy, 10(5), 1280-1292.
    DOI Scopus1 WoS2 Europe PMC1
    2020 Hong, L. E., Proudman, S., & Limaye, V. (2020). Interstitial pneumonia with autoimmune features in a patient with melanoma differentiation-associated gene 5 (MDA5) antibody. BMJ Case Reports, 13(11), e234946.
    DOI
    2020 Thombs, B. D., Kwakkenbos, L., Henry, R. S., Carrier, M. -E., Patten, S., Harb, S., . . . Ellis, K. (2020). Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study. JOURNAL OF PSYCHOSOMATIC RESEARCH, 139, 10 pages.
    DOI WoS5 Europe PMC2
    2020 Day, J., Otto, S., Cash, K., Eldi, P., Hissaria, P., Proudman, S., . . . Hayball, J. D. (2020). Aberrant expression of high mobility group box protein 1 in the idiopathic inflammatory myopathies. Frontiers in Cell and Developmental Biology, 8, 11 pages.
    DOI WoS1
    2020 Thombs, B. D., Kwakkenbos, L., Carrier, M. -E., Bourgeault, A., Tao, L., Harb, S., . . . Ostbo, N. (2020). Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients. JOURNAL OF PSYCHOSOMATIC RESEARCH, 135, 11 pages.
    DOI WoS12
    2020 Foers, A. D., Garnham, A. L., Smyth, G. K., Proudman, S. M., Cheng, L., Hill, A. F., . . . Wicks, I. P. (2020). Circulating small noncoding RNA biomarkers of response to triple disease-modifying antirheumatic drug therapy in white women with early rheumatoid arthritis. Journal of Rheumatology, 47(12), 1746-1751.
    DOI Scopus1 WoS2 Europe PMC1
    2020 Murray-Brown, W., Wilsdon, T. D., Weedon, H., Proudman, S., Sukumaran, S., Klebe, S., . . . Wechalekar, M. D. (2020). Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy. Journal for ImmunoTherapy of Cancer, 8(1), 6 pages.
    DOI Scopus4 WoS4 Europe PMC2
    2020 Reid, A. B., Wiese, M., McWilliams, L., Metcalf, R., Hall, C., Lee, A., . . . Proudman, S. M. (2020). Repeat serological testing for anti-citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis. Internal Medicine Journal, 50(7), 818-822.
    DOI
    2020 Ross, L., Stevens, W., Wilson, M., Huq, M., Strickland, G., Walker, J., . . . Nikpour, M. (2020). Performance of the 2017 EUSTAR activity index in an scleroderma cohort. Clinical Rheumatology, 39(12), 3701-3705.
    DOI
    2020 Proudman, S. (2020). Consensus statements for managing systemic sclerosis-associated interstitial lung disease. The Lancet Rheumatology, 2(2), e64-e65.
    DOI
    2020 Anderson, J., Lavender, M., Lau, E., Celermajer, D., Collins, N., Dwyer, N., . . . Strange, G. (2020). Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart Lung and Circulation, 29(10), 1459-1468.
    DOI
    2020 Ruediger, C., Nguyen, L., Black, R., Proudman, S., & Hill, C. (2020). Efficacy of Methotrexate in Polymyalgia Rheumatica in routine rheumatology clinical care.. Internal medicine journal, 50(9), 1067-1072.
    DOI Scopus2 WoS1
    2020 Quinlivan, A., Ross, L., & Proudman, S. (2020). Systemic sclerosis: Advances towards stratified medicine. Best Practice and Research: Clinical Rheumatology, 34(1), 22 pages.
    DOI Scopus2 WoS2 Europe PMC1
    2020 Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. S., Ferdowsi, N., Hansen, D., . . . Nikpour, M. (2020). The clinical and economic burden of systemic sclerosis related interstitial lung disease. Rheumatology (United Kingdom), 59(8), 1878-1888.
    DOI Scopus4 WoS7
    2020 Ross, L., Stevens, W., Wilson, M., Strickland, G., Walker, J., Sahhar, J., . . . Nikpour, M. (2020). Can patient-reported symptoms be used to measure disease activity in systemic sclerosis?. Arthritis Care and Research, 72(10), 1459-1465.
    DOI Scopus1 WoS3 Europe PMC2
    2020 Morrisroe, K., Hansen, D., Huq, M., Stevens, W., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2020). Incidence, risk factors and outcomes of cancer in systemic sclerosis. Arthritis Care and Research, 72(11), 1625-1635.
    DOI Scopus6 WoS5 Europe PMC4
    2020 Abbot, S., McWilliams, L., Spargo, L., de Costa, C., Ur-Rehman, Z., Proudman, S., & Bossingham, D. (2020). Scleroderma in Cairns: an epidemiological study. Internal Medicine Journal, 50(4), 445-452.
    DOI Scopus2 WoS2 Europe PMC1
    2019 Quinlivan, A., Proudman, S., Sahhar, J., Stevens, W., Nikpour, M., Major, G., . . . Youseff, P. (2019). Cost savings with a novel algorithm for early detection of systemic sclerosis-related pulmonary arterial hypertension: alternative scenario analyses. Internal Medicine Journal, 49(6), 781-785.
    DOI Scopus3 WoS3
    2019 Boulos, D., Proudman, S. M., Metcalf, R. G., McWilliams, L., Hall, C., & Wicks, I. P. (2019). The neutrophil-lymphocyte ratio in early rheumatoid arthritis and its ability to predict subsequent failure of triple therapy. Seminars in Arthritis and Rheumatism, 49(3), 373-376.
    DOI Scopus6 WoS6 Europe PMC6
    2019 Harel, D., Mills, S. D., Kwakkenbos, L., Carrier, M. -E., Nielsen, K., Portales, A., . . . Lambert, M. (2019). Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort. BMJ OPEN, 9(2), 10 pages.
    DOI WoS8 Europe PMC3
    2019 Metwally, M., Thabet, K., Bayoumi, A., Nikpour, M., Stevens, W., Sahhar, J., . . . Eslam, M. (2019). IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis. Scientific Reports, 9(1), 14834.
    DOI Scopus10 WoS6 Europe PMC3
    2019 Khoo, T., Stokes, M. B., Teo, K., Proudman, S., Basnayake, S., Sanders, P., & Limaye, V. (2019). Cardiac involvement in idiopathic inflammatory myopathies detected by cardiac magnetic resonance imaging. Clinical Rheumatology, 38(12), 3471-3476.
    DOI Scopus5 WoS6 Europe PMC2
    2019 Maundrell, A., Proudman, S., & Limaye, V. (2019). Prevalence of other connective tissue diseases in idiopathic inflammatory myopathies. Rheumatology International, 39(10), 1777-1781.
    DOI Scopus6 WoS6 Europe PMC3
    2019 Butler, E. A., Baron, M., Fogo, A. B., Frech, T., Ghossein, C., Hachulla, E., . . . Walker, U. A. (2019). Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology. Arthritis and Rheumatology, 71(6), 964-971.
    DOI Scopus14 WoS12 Europe PMC5
    2019 Khoo, T., Proudman, S., & Limaye, V. (2019). Silicone breast implants and depression, fibromyalgia and chronic fatigue syndrome in a rheumatology clinic population. Clinical Rheumatology, 38(5), 1271-1276.
    DOI Scopus7 WoS6 Europe PMC4
    2019 Wabe, N., Lee, A., Wechalekar, M., McWilliams, L., Proudman, S., & Wiese, M. (2019). Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patients. International Journal of Clinical Practice, 73(7), 9 pages.
    DOI Scopus4 WoS4 Europe PMC3
    2019 Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. -S., Ferdowsi, N., Hansen, D., . . . Nikpour, M. (2019). The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia. BMC Pulmonary Medicine, 19(1), 226-1-226-11.
    DOI Scopus1 WoS2
    2019 Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G. -S., Ferdowsi, N., Hill, C. L., . . . Nikpour, M. (2019). Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden. Arthritis Research and Therapy, 21(1), 299-1-299-12.
    DOI Scopus8 WoS8 Europe PMC1
    2019 López-Isac, E., Acosta-Herrera, M., Kerick, M., Assassi, S., Satpathy, A. T., Granja, J., . . . Chang, H. Y. (2019). GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nature Communications, 10(1), 14 pages.
    DOI Scopus31 WoS34 Europe PMC19
    2019 Ross, L., Prior, D., Proudman, S., Vacca, A., Baron, M., & Nikpour, M. (2019). Defining primary systemic sclerosis heart involvement: a scoping literature review. Seminars in Arthritis and Rheumatism, 48(5), 874-887.
    DOI Scopus9 WoS9
    2019 Moxey, J., Huq, M., Proudman, S., Sahhar, J., Ngian, G. S., Walker, J., . . . Nikpour, M. (2019). Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis. Arthritis Research and Therapy, 21(1), 57-1-57-12.
    DOI Scopus11 WoS12 Europe PMC2
    2019 Richard, N., Hudson, M., Wang, M., Gyger, G., Proudman, S., Stevens, W., . . . Baron, M. (2019). Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. Rheumatology, 58(4), 636-644.
    DOI Scopus16 WoS19 Europe PMC7
    2019 McMahan, Z. H., Frech, T., Berrocal, V., Lim, D., Bruni, C., Matucci-Cerinic, M., . . . Khanna, D. (2019). Longitudinal assessment of patient-reported outcome measures in systemic sclerosis patients with gastroesophageal reflux disease - Scleroderma clinical trials consortium. Journal of Rheumatology, 46(1), 78-84.
    DOI Scopus5 WoS6 Europe PMC2
    2019 Ferdowsi, N., Huq, M., Stevens, W., Hudson, M., Wang, M., Tay, T., . . . Nikpour, M. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases, 78(6), 807-816.
    DOI Scopus10 WoS9 Europe PMC1
    2018 Abbot, S., Bossingham, D., Proudman, S., de Costa, C., & Ho-Huynh, A. (2018). Risk factors for the development of systemic sclerosis: A systematic review of the literature. Rheumatology Advances in Practice, 2(2), 1-12.
    DOI Scopus6
    2018 Massolino, R. I., Hissaria, P., Lee, A., & Proudman, S. M. (2018). Tocilizumab-induced drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient with rheumatoid arthritis. Rheumatology Advances in Practice, 2(2), 1-2.
    DOI Scopus1
    2018 Wilsdon, T., & Proudman, S. (2018). Early arthritis: A guide to assessment. Medicine Today, 19(11), 12-18.
    2018 Morrisroe, K., Hudson, M., Baron, M., De Vries-Bouwstra, J., Carreira, P., Wuttge, D., . . . Nikpour, M. (2018). Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. Clinical and Experimental Rheumatology, 36(Suppl. 113), S53-S60.
    Scopus8 WoS9 Europe PMC2
    2018 Ross, L., Stevens, W., Rabusa, C., Wilson, M., Ferdowsi, N., Walker, J., . . . Nikpour, M. (2018). The role of inflammatory markers in assessment of disease activity in systemic sclerosis. Clinical and Experimental Rheumatology, 36(4), S126-S134.
    Scopus13 Europe PMC5
    2018 Thakkar, V., Patterson, K., Stevens, W., Wilson, M., Roddy, J., Sahhar, J., . . . Nikpour, M. (2018). Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations. Clinical Rheumatology, 37(6), 1563-1571.
    DOI Scopus5 WoS6 Europe PMC2
    2018 Cole, S., Walsh, A., Yin, X., Wechalekar, M., Smith, M., Proudman, S., . . . Guo, Y. (2018). Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus. Arthritis Research and Therapy, 20(1), 14 pages.
    DOI Scopus36 WoS36 Europe PMC24
    2018 Strange, G., Lau, E., Giannoulatou, E., Corrigan, C., Kotlyar, E., Kermeen, F., . . . Keogh, A. (2018). Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand. Heart Lung and Circulation, 27(11), 1368-1375.
    DOI Scopus14 WoS15 Europe PMC4
    2018 Herrick, A., Peytrignet, S., Lunt, M., Pan, X., Hesselstrand, R., Mouthon, L., . . . Denton, C. (2018). Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Annals of the Rheumatic Diseases, 77(4), 563-570.
    DOI Scopus28 WoS27 Europe PMC13
    2018 Guo, Y., Walsh, A., Canavan, M., Wechalekar, M., Cole, S., Yin, X., . . . Nagpal, S. (2018). Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. PLoS ONE, 13(2), 17 pages.
    DOI Scopus51 WoS50 Europe PMC25
    2018 Morrisroe, K., Sudararajan, V., Stevens, W., Sahhar, J., Zochling, J., Roddy, J., . . . Nikpour, M. (2018). Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life.. Rheumatology (Oxford, England), 57(1), 73-83.
    DOI Scopus11 WoS9 Europe PMC4
    2018 Peytrignet, S., Denton, C., Lunt, M., Hesselstrand, R., Mouthon, L., Silman, A., . . . Herrick, A. (2018). Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.. Rheumatology (Oxford, England), 57(2), 370-381.
    DOI Scopus24 WoS24 Europe PMC9
    2017 Morrisroe, K., Stevens, W., Sahhar, J., Ngian, G., Rabusa, C., Ferdowsi, N., . . . Nikpour, M. (2017). Quantifying the direct public health care cost of systemic sclerosis. Medicine, 96(48), e8503-1-e8503-11.
    DOI Scopus9 WoS8 Europe PMC2
    2017 Hopkins, A., Vitry, A., O'Doherty, C., Proudman, S., & Wiese, M. (2017). Changes to the Australian Pharmaceutical Benefit Scheme restrictions for biological disease-modifying antirheumatic drugs have influenced the use of leflunomide. International Journal of Rheumatic Diseases, 20(11), 1795-1797.
    DOI Scopus1 WoS1
    2017 Morrisroe, K., Stevens, W., Proudman, S., & Nikpour, M. (2017). A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults. International Journal of Rheumatic Diseases, 20(11), 1728-1750.
    DOI Scopus8 WoS7 Europe PMC1
    2017 Rasch, L. A., Boers, M., Hill, C. L., Voshaar, M., Hoogland, W., De Wit, M., . . . Van Tuyl, L. H. D. (2017). Validating rheumatoid arthritis remission using the patients' perspective: Results from a special interest group at OMERACT 2016. Journal of Rheumatology, 44(12), 1889-1893.
    DOI Scopus6 WoS5 Europe PMC4
    2017 Walsh, A., Wechalekar, M., Guo, Y., Yin, X., Weedon, H., Proudman, S., . . . Nagpal, S. (2017). Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways. PLoS ONE, 12(9), e0183928-1-e0183928-16.
    DOI Scopus16 WoS17 Europe PMC11
    2017 Wabe, N., Wojciechowski, J., Wechalekar, M. D., Cleland, L. G., McWilliams, L., Lee, A., . . . Wiese, M. D. (2017). Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy. International Journal of Rheumatic Diseases, 20(10), 1447-1456.
    DOI Scopus5 WoS5 Europe PMC1
    2017 Herrick, A., Pan, X., Peytrignet, S., Lunt, M., Hesselstrand, R., Mouthon, L., . . . Denton, C. (2017). Treatment outcome in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases, 76(7), 1207-1218.
    DOI Scopus59 WoS65 Europe PMC28
    2017 Wabe, N., Lee, A., Wechalekar, M., McWilliams, L., Proudman, S., & Wiese, M. (2017). Adherence to combination DMARD therapy and treatment outcomes in rheumatoid arthritis: a longitudinal study of new and existing DMARD users. Rheumatology International, 37(6), 897-904.
    DOI Scopus11 WoS13 Europe PMC11
    2017 Wechalekar, M., Quinn, S., Lester, S., Metcalf, R., Shanahan, E., Walker, J., . . . Proudman, S. (2017). A treat-to-target strategy preserves work capacity in a rheumatoid arthritis inception cohort treated with combination conventional DMARD therapy. Journal of Clinical Rheumatology, 23(3), 131-137.
    DOI Scopus5 WoS5 Europe PMC4
    2017 Day, J., Limaye, V., Proudman, S., Hayball, J., & Hissaria, P. (2017). The utility of monitoring peripheral blood lymphocyte subsets by flow cytometric analysis in patients with rheumatological diseases treated with rituximab. Autoimmunity Reviews, 16(5), 542-547.
    DOI Scopus3 WoS3 Europe PMC1
    2017 Morrisroe, K., Stevens, W., Sahhar, J., Rabusa, C., Nikpour, M., Proudman, S., . . . Zochling, J. (2017). Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme. Arthritis Research and Therapy, 19(1), 42-1-42-10.
    DOI Scopus39 WoS40 Europe PMC18
    2017 Nikpour, M., Proudman, S., Morrisroe, K., Sahhar, J. M., & Stevens, W. (2017). The Australian scleroderma interest group and database: 10 years of screening to save lives. Medical Journal of Australia, 206(5), 229-229.e1.
    DOI Scopus1 WoS1 Europe PMC1
    2017 Boulos, D., Ngian, G., Rajadurai, A., Elford, K., Stevens, W., Proudman, S., . . . Sahhar, J. (2017). Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease. International Journal of Rheumatic Diseases, 20(4), 481-488.
    DOI Scopus9 WoS8 Europe PMC3
    2017 Otero, C., Assassi, S., Hudson, M., Mayes, M., Estrada-Y-Martin, R., Pedroza, C., . . . Fritzler, M. (2017). Antifibrillarin antibodies are associated with native north American ethnicity and poorer survival in systemic sclerosis. Journal of Rheumatology, 44(6), 799-805.
    DOI Scopus11 WoS11 Europe PMC3
    2017 Tay, T., Ferdowsi, N., Baron, M., Stevens, W., Hudson, M., Proudman, S., . . . Damage Index Working Group of the Scleroderma Clinical Trials Consortium. (2017). Measures of disease status in systemic sclerosis: a systematic review. Seminars in Arthritis and Rheumatism, 46(4), 473-487.
    DOI Scopus12 WoS12 Europe PMC6
    2017 Hoa, S., Stern, E. P., Denton, C. P., Hudson, M., Baron, M., Frech, T., . . . Varga, J. (2017). Towards developing criteria for scleroderma renal crisis: A scoping review. Autoimmunity Reviews, 16(4), 407-415.
    DOI Scopus21 Europe PMC11
    2017 Ramos-Remus, C., Ramirez-Gomez, A., Brambila-Barba, V., Barajas-Ochoa, A., Castillo-Ortiz, J. D., Adebajo, A. O., . . . Mæland, E. (2017). Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clinical Rheumatology, 36(3), 485-497.
    DOI Scopus15 WoS13 Europe PMC4
    2017 Guo, Y., Walsh, A., Fearon, U., Smith, M., Wechalekar, M., Yin, X., . . . Nagpal, S. (2017). CD40L-dependent pathway is active at various stages of rheumatoid arthritis disease progression. Journal of Immunology, 198(11), 4490-4501.
    DOI Scopus35 WoS36 Europe PMC26
    2017 Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G., Zochling, J., . . . ustralian Scleroderma Interest Group (ASIG). (2017). Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis. Clinical and Experimental Rheumatology, 35(4 Suppl. 106), S130-S137.
    Scopus7 WoS5 Europe PMC1
    2017 Morrisroe, K., Stevens, W., Huq, M., Prior, D., Sahhar, J., Ngian, G., . . . Walker, J. (2017). Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Research and Therapy, 19(1), 122.
    DOI Scopus28 WoS32 Europe PMC17
    2017 Proudman, S. M., Huq, M., Stevens, W., Wilson, M. E., Sahhar, J., Baron, M., . . . Scheja, A. (2017). What have multicentre registries across the world taught us about the disease features of systemic sclerosis?. Journal of Scleroderma and Related Disorders, 2(3), 169-182.
    DOI Scopus10
    2017 Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G. S., Zochling, J., . . . Walker, J. (2017). Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis. Journal of Scleroderma and Related Disorders, 2(3), 188-195.
    DOI Scopus2
    2017 Tay, T., Huq, M., Ferdowsi, N., Stevens, W., Sahhar, J., Ngian, G. S., . . . Nikpour, M. (2017). Early accrual of organ damage in systemic sclerosis: Rationale for development of a disease damage index. Journal of Scleroderma and Related Disorders, 2(2), 127-134.
    DOI Scopus3
    2017 Day, J., Otto, S., Proudman, S., Hayball, J. D., & Limaye, V. (2017). Dysregulated innate immune function in the aetiopathogenesis of idiopathic inflammatory myopathies. Autoimmunity Reviews, 16(1), 87-95.
    DOI Scopus11 WoS11 Europe PMC6
    2017 Hopkins, A., Moghaddami, M., Foster, D., Proudman, S., Upton, R., & Wiese, M. (2017). Intracellular CD3⁺ T-lymphocyte teriflunomide concentration is poorly correlated with and has greater variability than unbound plasma teriflunomide concentration. Drug Metabolism Disposition, 45(1), 8-16.
    DOI Scopus6 WoS5 Europe PMC1
    2017 Hopkins, A., Wiese, M., O Doherty, C., & Proudman, S. (2017). Putting recommendations into practice: Australian rheumatologists’ opinions on leflunomide use in rheumatoid arthritis. Clinical Rheumatology, 36(4), 791-798.
    DOI Scopus2 WoS2 Europe PMC2
    2017 Hao, Y., Hudson, M., Baron, M., Carreira, P., Stevens, W., Rabusa, C., . . . Nikpour, M. (2017). Early mortality in a multinational systemic sclerosis inception cohort. Arthritis and Rheumatology, 69(5), 1067-1077.
    DOI Scopus88 WoS80 Europe PMC36
    2017 Foreman, C., Russo, P., Davies, N., Hissaria, P., Proudman, S., Hughes, T., & Limaye, V. (2017). Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients. Internal Medicine Journal, 47(1), 112-115.
    DOI Scopus5 WoS5 Europe PMC2
    2017 Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., Mcwilliams, L., Lee, A., . . . Wiese, M. (2017). Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis. International Journal of Rheumatic Diseases, 20(5), 576-583.
    DOI Scopus4 WoS5 Europe PMC4
    2016 Hopkins, A., Wiese, M., Proudman, S., O'Doherty, C., Upton, R., & Foster, D. (2016). Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis. British Journal of Clinical Pharmacology, 81(1), 113-123.
    DOI Scopus15 WoS12 Europe PMC6
    2016 Hill, C., March, L., Aitken, D., Lester, S., Battersby, R., Hynes, K., . . . Jones, G. (2016). Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. Annals of the Rheumatic Diseases, 75(1), 23-29.
    DOI Scopus61 WoS52 Europe PMC34
    2016 Calderone, A., Stevens, W., Prior, D., Nandurkar, H., Gabbay, E., Proudman, S., . . . Nikpour, M. (2016). Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol. BMJ Open, 6(12), e011028-1-e011028-12.
    DOI Scopus9 WoS9 Europe PMC5
    2016 Tieu, J., & Proudman, S. (2016). Systemic sclerosis a step-by-step guide to a difficult diagnosis. Medicine Today, 17(9), 47-54.
    2016 Esposito, J., Brown, Z., Stevens, W., Sahhar, J., Rabusa, C., Zochling, J., . . . Nikpour, M. (2016). The association of low complement with disease activity in systemic sclerosis: a prospective cohort study. Arthritis Research and Therapy, 18(1), 246-1-246-12.
    DOI Scopus7 WoS5 Europe PMC4
    2016 Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Proudman, S., & Nikpour, M. (2016). Determinants of unemployment amongst Australian systemic sclerosis patients: Results from a multicentre cohort study. Clinical and Experimental Rheumatology, 34(5), 79-84.
    Scopus13 WoS12 Europe PMC5
    2016 Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Proudman, S., Nikpour, M., & The Australian Scleroderma Interest Group (ASIG). (2016). Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study. BMC Pulmonary Medicine, 16(1), 134-1-134-8.
    DOI WoS22 Europe PMC11
    2016 Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Proudman, S. M., & Nikpour, M. (2016). Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: Results from a large multicenter cohort study. BMC Pulmonary Medicine, 16(1), 33.
    DOI Scopus21
    2016 Valenzuela, A., Baron, M., Herrick, A., Proudman, S., Stevens, W., Rodriguez-Reyna, T., . . . Chung, L. (2016). Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. Seminars in Arthritis and Rheumatism, 46(3), 344-349.
    DOI Scopus40 WoS35 Europe PMC11
    2016 Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., McWilliams, L., Lee, A., . . . Wiese, M. (2016). Effect of adherence to protocolized targeted intensifications of disease-modifying antirheumatic drugs on treatment outcomes in rheumatoid arthritis: results from an Australian early arthritis cohort. The Journal of Rheumatology, 43(9), 1643-1649.
    DOI Scopus7 WoS7 Europe PMC4
    2016 Proudman, S., Nikpour, M., & Hudson, M. (2016). Improving care of autoimmune connective tissue diseases: Lessons from longitudinal cohorts. Best Practice and Research: Clinical Rheumatology, 30(1), 1-2.
    DOI
    2016 Hoa, S., Hudson, M., Troyanov, Y., Proudman, S., Walker, J., Stevens, W., . . . Fritzler, M. (2016). Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: Clinical associations. Medicine (United States), 95(35), 12 pages.
    DOI Scopus27 WoS25 Europe PMC15
    2016 Wojciechowski, J., Wiese, M., Proudman, S., Foster, D., & Upton, R. (2016). A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity. British Journal of Clinical Pharmacology, 81(6), 1046-1057.
    DOI
    2016 Hopkins, A., Proudman, S., Vitry, A., Sorich, M., Cleland, L., & Wiese, M. (2016). Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia. Medical Journal of Australia, 204(2), 64-68.e1.
    DOI Scopus11 WoS9 Europe PMC6
    2016 Khanna, D., Berrocal, V., Giannini, E., Seibold, J., Merkel, P., Mayes, M., . . . Furst, D. (2016). The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis. Arthritis and Rheumatology, 68(2), 299-311.
    DOI Scopus63 WoS72 Europe PMC31
    2016 Khanna, D., Berrocal, V. J., Giannini, E. H., Seibold, J. R., Merkel, P. A., Mayes, M. D., . . . Furst, D. E. (2016). The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis. Arthritis Care and Research, 68(2), 167-178.
    DOI Scopus8 WoS6 Europe PMC2
    2016 Wechalekar, M., Lester, S., Hill, C., Lee, A., Rischmueller, M., Smith, M., . . . Proudman, S. (2016). Active foot synovitis in patients with rheumatoid arthritis: unstable remission status, radiographic progression, and worse functional outcomes in patients with foot synovitis in apparent remission. Arthritis Care and Research, 68(11), 1616-1623.
    DOI Scopus22 WoS25 Europe PMC13
    2016 Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., McWilliams, L., Lee, A., . . . Wiese, M. (2016). Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?. International Journal of Clinical Practice, 70(4), 340-350.
    DOI Scopus2 WoS2 Europe PMC1
    2016 Owen, C., Ngian, G., Elford, K., Moore, O., Stevens, W., Nikpour, M., . . . Sahhar, J. (2016). Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study. Clinical and Experimental Rheumatology, 34(5 (Suppl.100)), 170-176.
    Scopus33 WoS25 Europe PMC15
    2016 Nenke, M., Lewis, J., Rankin, W., McWilliams, L., Metcalf, R., Proudman, S., & Torpy, D. (2016). Reduced corticosteroid-binding globulin cleavage in active rheumatoid arthritis. Clinical Endocrinology, 85(3), 369-377.
    DOI Scopus9 WoS6 Europe PMC4
    2016 Hynes, K., Bright, R., Proudman, S., Haynes, D., Gronthos, S., & Bartold, M. (2016). Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: a systematic review. Seminars in Arthritis and Rheumatism, 46(1), 1-19.
    DOI Scopus16 WoS17 Europe PMC12
    2016 Nikpour, M., Prior, D., Proudman, S., & Stevens, W. (2016). Author reply. Internal Medicine Journal, 46(6), 751-752.
    DOI
    2016 Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Sahhar, J., G Walker, J., . . . Nikpour, M. (2016). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clinical and Experimental Rheumatology, 34(5 (Suppl.100)), 129-136.
    Scopus9 WoS9 Europe PMC3
    2016 Khanna, D., Denton, C., Merkel, P., Krieg, T., Le Brun, F., Marr, A., . . . Balbir-Gurman, A. (2016). Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: Dual-1 and Dual-2 randomized clinical trials. JAMA - Journal of the American Medical Association, 315(18), 1975-1988.
    DOI Scopus66 Europe PMC36
    2016 Tieu, J., Lester, S., Whittle, S., Peh, C. A., Goldblatt, F., Proudman, S., . . . Hill, C. (2016). RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF USE IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 46, 35.
    2016 Leclair, V., Hudson, M., Proudman, S. M., Stevens, W. M., Fritzler, M. J., Wang, M., . . . Youssef, P. (2016). Subsets in systemic sclerosis: One size does not fit all. Journal of Scleroderma and Related Disorders, 1(3), 298-306.
    DOI Scopus5
    2016 Hopkins, A. M., Proudman, S. M., Vitry, A. I., Sorich, M. J., Cleland, L. G., & Wiese, M. D. (2016). Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia. MEDICAL JOURNAL OF AUSTRALIA, 204(2), 64-+.
    DOI
    2015 Wechalekar, M. D., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). Foot Synovitis in Patients with Rheumatoid Arthritis in Apparent Remission Is Associated with Unstable Remission Status, Radiographic Progression and Worse Long-Term Functional Outcomes. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages.
    2015 Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., McWilliams, L., Lee, A., . . . Wiese, M. D. (2015). Effects of Drug Induced Toxicity on Patient Reported Outcomes in Early Rheumatoid Arthritis Treated-to-Target Using Conventional Triple DMARD Therapy. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages.
    2015 Johnson, S. R., Elarabi, M., Proudman, S., Frech, T. M., Sahhar, J., Stevens, W., . . . Hudson, M. (2015). Exposure to ACE Inhibitors Prior to Onset of Scleroderma Renal Crisis Is Not Associated with Increased Risk of Mortality in a Large Retrospective Cohort Study. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages.
    2015 Valenzuela, A., Baron, M., Herrick, A. L., Proudman, S., Stevens, W., Sofia Rodriguez-Reyna, T., . . . Chung, L. (2015). Calcinosis Is Associated with Digital Ulcers and Osteoporosis in Patients with Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages.
    2015 Hudson, M., Baron, M., Wang, M., Rabusa, C., Proudman, S., Nikpour, M., & Stevens, W. (2015). Health-Related Quality of Life in Early Systemic Sclerosis. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages.
    2015 Ferdowsi, N., Huq, M., Burchell, J., Mancuso, S., Tay, T., Stevens, W., . . . Nikpour, M. (2015). Development of a Disease Damage Index in Systemic Sclerosis Using Consensus and Data Driven Methods. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages.
    2015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. J. (2015). Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity, 48(8), 542-551.
    DOI Scopus12 WoS12 Europe PMC5
    2015 Moore, O., Proudman, S., Goh, N., Corte, T., Rouse, H., Hennessy, O., . . . Nikpour, M. (2015). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clinical and Experimental Rheumatology, 33(4 (Suppl. 91)), 111-116.
    Scopus47 WoS49
    2015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Salazar, G. (2015). Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival. Clinical and Experimental Rheumatology, 33(4), 131-135.
    Scopus27 WoS29 Europe PMC15
    2015 Bartold, P., & Proudman, S. (2015). Is there evidence indicating a link between periodontitis and rheumatoid arthritis?. International Journal of Clinical Rheumatology, 10(4), 215-218.
    DOI
    2015 Quinlivan, A., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal, 45(11), 1134-1140.
    DOI Scopus18 WoS18 Europe PMC9
    2015 Hopkins, A., Wiese, M., Proudman, S., O'Doherty, C., Foster, D., & Upton, R. (2015). Semiphysiologically based pharmacokinetic model of leflunomide disposition in rheumatoid arthritis patients. CPT: Pharmacometrics and Systems Pharmacology, 4(6), 362-371.
    DOI Scopus10 Europe PMC6
    2015 Patterson, K., Roberts-Thomson, P., Lester, S., Tan, J., Hakendorf, P., Rischmueller, M., . . . Walker, J. (2015). Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysis. Arthritis and Rheumatology, 67(12), 3234-3244.
    DOI Scopus60 WoS61 Europe PMC31
    2015 Proudman, S., Cleland, L., Metcalf, R., Sullivan, T., Spargo, L., & James, M. (2015). Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritis. The British Journal of Nutrition, 114(06), 885-890.
    DOI Scopus18 WoS21 Europe PMC15
    2015 Thakkar, V., Nikpour, M., Stevens, W., & Proudman, S. (2015). Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension. Internal Medicine Journal, 45(3), 248-254.
    DOI Scopus8 WoS7 Europe PMC4
    2015 Bright, R., Proudman, S., Rosenstein, E., & Bartold, P. (2015). Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis?. Medical Hypotheses, 84(6), 570-576.
    DOI Scopus21 WoS18 Europe PMC14
    2015 Moghaddami, M., James, M., Proudman, S., & Cleland, L. (2015). Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids, 97, 7-12.
    DOI Scopus8 WoS8 Europe PMC2
    2015 Wabe, N., Sorich, M., Wechalekar, M., Cleland, L., McWilliams, L., Lee, A., . . . Wiese, M. (2015). Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years. Arthritis Research and Therapy, 17(1), 48-1-48-14.
    DOI Scopus16 WoS18 Europe PMC11
    2015 Mohamed, H., Sorich, M., Kowalski, S., McKinnon, R., Proudman, S., Cleland, L., & Wiese, M. (2015). The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies - a systematic review. European Journal of Clinical Pharmacology, 71(4), 411-423.
    DOI Scopus11 WoS10 Europe PMC6
    2015 Khanna, D., Mittoo, S., Aggarwal, R., Proudman, S., Dalbeth, N., Matteson, E., . . . Strand, V. (2015). Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - report from OMERACT CTD-ILD Working Group. The Journal of rheumatology, 42(11), 2168-2171.
    DOI Scopus78 WoS77 Europe PMC46
    2015 Morrisroe, K., Nikpour, M., & Proudman, S. (2015). Musculoskeletal manifestations of systemic sclerosis. Rheumatic Disease Clinics of North America, 41(3), 507-518.
    DOI Scopus28 WoS25 Europe PMC10
    2015 Wojciechowski, J., Wiese, M., Proudman, S., Foster, D., & Upton, R. (2015). A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine. British journal of clinical pharmacology, 79(5), 777-788.
    DOI Scopus5 WoS4 Europe PMC4
    2015 Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research and Therapy, 17(1), 23.
    DOI Scopus60 WoS65 Europe PMC40
    2015 Proudman, S., James, M., Spargo, L., Metcalf, R., Sullivan, T., Rischmueller, M., . . . Cleland, L. (2015). Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Annals of the Rheumatic Diseases, 74(1), 89-95.
    DOI Scopus95 WoS90 Europe PMC64
    2015 McComish, J., Mundy, J., Sullivan, T., Proudman, S., & Hissaria, P. (2015). Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters. International Journal of Rheumatic Diseases, 18(4), 421-432.
    DOI Scopus12 WoS11 Europe PMC7
    2014 Wiese, M., Alotaibi, N., O'Doherty, C., Sorich, M., Suppiah, V., Cleland, L., & Proudman, S. (2014). Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis. Pharmacogenomics Journal, 14(4), 350-355.
    DOI Scopus19 WoS17 Europe PMC12
    2014 Saketkoo, L., Mittoo, S., Huscher, D., Khanna, D., Dellaripa, P., Distler, O., . . . Seibold, J. (2014). Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Thorax, 69(5), 428-436.
    DOI Scopus73 WoS74 Europe PMC47
    2014 Cleland, L., Proudman, S., & James, M. (2014). RE: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. Journal of the National Cancer Institute, 106(4), dju022-1.
    DOI Scopus2 WoS2 Europe PMC2
    2014 Kaur, S., Bright, R., Proudman, S., & Bartold, P. (2014). Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 44(2), 113-122.
    DOI Scopus72 WoS61 Europe PMC45
    2014 Hopkins, A., O'Doherty, C., Foster, D., Suppiah, V., Upton, R., Spargo, L., . . . Wiese, M. (2014). The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity. Journal of Clinical Pharmacy and Therapeutics, 39(5), 555-560.
    DOI Scopus6 WoS5 Europe PMC4
    2014 Hopkins, A. M., O'Doherty, C. E., Foster, D. J. R., Upton, R. N., Proudman, S. M., & Wiese, M. D. (2014). Individualization of leflunomide dosing in rheumatoid arthritis patients. Personalized Medicine, 11(4), 449-461.
    DOI Scopus6 WoS6
    2014 Black, R., Spargo, L., Schultz, C., Chatterton, B., Cleland, L., Lester, S., . . . Proudman, S. (2014). Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care & Research, 66(4), 515-522.
    DOI Scopus12 WoS12 Europe PMC7
    2014 Vacca, A., Meune, C., Gordon, J., Chung, L., Proudman, S., Assassi, S., . . . Allanore, Y. (2014). Cardiac arrhythmias and conduction defects in systemic sclerosis. Rheumatology, 53(7), 1172-1177.
    DOI Scopus47 WoS46 Europe PMC27
    2014 Morrisroe, K., Stevens, W., Nandurkar, H., Prior, D., Thakkar, V., Roddy, J., . . . Nikpour, M. (2014). The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis. Clinical and Experimental Rheumatology, 32(6 Suppl. 86), S133-S137.
    Scopus23 WoS18 Europe PMC8
    2014 Hudson, M., Baron, M., Tatibouet, S., Furst, D., Khanna, D., Hummers, L., . . . Westhovens, R. (2014). Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey. Seminars in Arthritis and Rheumatism, 43(5), 666-672.
    DOI Scopus76 Europe PMC38
    2014 Lake, F., & Proudman, S. (2014). Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Seminars in Respiratory and Critical Care Medicine, 35(2), 222-238.
    DOI Scopus44 WoS42 Europe PMC20
    2014 Osthoff, M., Ngian, G., Dean, M., Nikpour, M., Stevens, W., Proudman, S., . . . Sahhar, J. (2014). Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study. Arthritis Research and Therapy, 16(1), 480-1-480-11.
    DOI Scopus11 WoS11 Europe PMC8
    2014 Zochling, J., Newell, F., Charlesworth, J., Leo, P., Stankovich, J., Cortes, A., . . . Brown, M. (2014). An immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Research & Therapy, 16(5), 438-1-438-7.
    DOI Scopus36 WoS36 Europe PMC26
    2014 Wiese, M. D., Hopkins, A., Spargo, L., McWilliams, L., O'Doherty, C., Cleland, L. G., & Proudman, S. (2014). Patient, Genetic and Disease Factors Influence the Response to the Disease Modifying Anti-Rheumatic Drug Leflunomide. ARTHRITIS & RHEUMATOLOGY, 66, S1102.
    WoS1
    2013 Thakkar, V., Stevens, W., Prior, D., Youssef, P., Liew, D., Gabbay, E., . . . Nikpour, M. (2013). The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy, 15(6), R193-1-R193-11.
    DOI Scopus36 WoS37 Europe PMC23
    2013 Nikpour, M., Stevens, W., Proudman, S., Buchbinder, R., Prior, D., Zochling, J., . . . Nandurkar, H. (2013). Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?. Internal Medicine Journal, 43(5), 599-603.
    DOI Scopus9 WoS9 Europe PMC4
    2013 Moore, O., Goh, N., Corte, T., Rouse, H., Hennessy, O., Thakkar, V., . . . Nikpour, M. (2013). Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology, 52(1), 155-160.
    DOI Scopus120 WoS108 Europe PMC73
    2012 Ngian, G., Sahhar, J., Proudman, S., Stevens, W., Wicks, I., & Van Doornum, S. (2012). Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. ARD online, 71(12), 1980-1983.
    DOI Scopus63 WoS60 Europe PMC32
    2012 O'Doherty, C., Schnabl, M., Spargo, L., Cleland, L., James, M., Proudman, S., & Wiese, M. (2012). Association of DHODH haplotype variants and response to leflunomide treatment in rheumatoid arthritis. Pharmagenomics, 13(12), 1427-1434.
    DOI Scopus20 WoS21 Europe PMC18
    2012 Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew, D., . . . Nikpour, M. (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research & Therapy, 14(3), 1-10.
    DOI Scopus71 WoS67 Europe PMC38
    2012 Graf, S., Lester, S., Nossent, J., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Research & Therapy, 14(1), 1-7.
    DOI Scopus28 WoS29 Europe PMC21
    2012 Wechalekar, M., Lester, S., Proudman, S., Cleland, L., Whittle, S., Rischmueller, M., & Hill, C. (2012). Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis and Rheumatism, 64(5), 1316-1322.
    DOI Scopus40 WoS38 Europe PMC28
    2012 Ngian, G., Stevens, W., Prior, D., Gabbay, E., Roddy, J., Tran, A., . . . Nikpour, M. (2012). Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy, 14(R213), 1-9.
    DOI Scopus58 WoS62 Europe PMC43
    2012 Marchant, C., Smith, M., Proudman, S., Haynes, D., & Bartold, P. (2012). Effect of Porphyromonas gingivalis on citrullination of proteins by macrophages in vitro. Journal of Periodontology, Online(9), 1-15.
    DOI Scopus11 WoS13 Europe PMC7
    2012 Wiese, M., Schnabl, M., O'Doherty, C., Spargo, L., Sorich, M., Cleland, L., & Proudman, S. (2012). Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis. Arthritis Research & Therapy, 14(4), 1-9.
    DOI Scopus34 WoS33 Europe PMC27
    2012 Dalton, B., McNeil, K., Keogh, A., Williams, T., Proudman, S., Gabbay, E., . . . Boland, J. (2012). Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension. International Journal of Clinical Practice, 66(11), 1117-1124.
    DOI Scopus1
    2012 Chen, J. Y., Limaye, V. S., Jain, R., Lu, T. Y., Proudman, S. M., & Raymond, G. L. (2012). Pulsed intravenous cyclophosphamide for SLE retinal vasculitis. Retinal Cases and Brief Reports, 6(1), 111-115.
    DOI
    2011 Black, R., Limaye, V., Proudman, S., Spargo, L., & Cleland, L. (2011). THE UTILITY OF THE VITAL ACTIVITIES AND LIFESTYLE INDEX (VALI) IN THE ASSESSMENT OF FIBROMYALGIA PATIENTS. INTERNAL MEDICINE JOURNAL, 41, 28-29.
    2011 Cohen, S., Proudman, S., Kivitz, A., Burch, F., Donohue, J., Burstein, D., . . . Zack, D. (2011). A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Research and Therapy, 13(4), R125-1-R125-12.
    DOI Scopus124 WoS105 Europe PMC85
    2011 Nikpour, M., Hissaria, P., Byron, J., Sahhar, J., Micallef, M., Paspaliaris, W., . . . Stevens, W. (2011). Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Research & Therapy, 13(6), 1-13.
    DOI Scopus104 WoS96 Europe PMC70
    2011 Gregory, M., Lester, S., Cook-Johnson, R., Gibson, R., Proudman, S., Cleland, L., & James, M. (2011). Fatty acid desaturase 2 promoter mutation is not responsible for Δ6-desaturase deficiency. European Journal of Human Genetics, 19(11), 1202-1204.
    DOI Scopus6 WoS4 Europe PMC2
    2011 Rakhila, H., Rozek, T., Hopkins, A., Proudman, S., Cleland, L., James, M., & Wiese, M. (2011). Quantitation of total and free teriflunomide (A77 1726) in human plasma by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 55(2), 325-331.
    DOI Scopus29 WoS30 Europe PMC16
    2011 Keogh, A., Strange, G., McNeil, K., Williams, T., Gabbay, E., Proudman, S., . . . Dalton, B. (2011). The Bosentan Patient Registry: long-term survival in pulmonary arterial hypertension. Internal Medicine Journal, 41(3), 227-234.
    DOI Scopus25 WoS24 Europe PMC20
    2011 Ngian, G., Nikpour, M., Byron, J., Tran, A., Roddy, J., Minson, R., . . . Proudman, S. (2011). SURVIVAL IN AUSTRALIAN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION. INTERNAL MEDICINE JOURNAL, 41, 12.
    WoS2
    2011 Nikpour, M., Proudman, S., Byron, J., Zochling, J., Roddy, J., Sahhar, J., . . . Stevens, W. (2011). MORTALITY AND CAUSES OF DEATH IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT. INTERNAL MEDICINE JOURNAL, 41, 12.
    2011 Bejarano, V., Conaghan, P. G., & Proudman, S. M. (2011). Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis (Annals of the Rheumatic Diseases (2009) 68, (761-763)). Annals of the Rheumatic Diseases, 70(8), 1519.
    DOI
    2010 Nikpour, M., Micallef, M., Byron, J., Hissaria, P., Paspaliaris, W., Sahhar, J., . . . Stevens, W. (2010). PREVALENCE AND CORRELATES OF ANTIBODIES TO RNA POLYMERASE Ill IN SYSTEMIC SCLEROSIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(2), S82.
    WoS1
    2010 Stevens, W., Byron, J., Nash, P., Zochling, J., Gabbay, E., Chan, M., . . . Proudman, S. (2010). PULMONARY ARTERIAL HYPERTENSION IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(2), S76-S77.
    2010 Proudman, S. (2010). Why screen patients with scleroderma for lung complications?. Medicine Today, 11(2), 63-68.
    2010 Nikpour, M., Byron, J., Zochling, J., Chan, M., Nash, P., Sahhar, J., . . . Stevens, W. (2010). DESCRIBING ORGAN DAMAGE IN SYSTEMIC SCLEROSIS. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 28(2), S113-S114.
    2010 Caughey, G., James, M., Proudman, S., & Cleland, L. (2010). Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients. Complementary Therapies in Medicine, 18(3-4), 171-174.
    DOI Scopus28 WoS27 Europe PMC13
    2010 Nikpour, M., Stevens, W., Herrick, A., & Proudman, S. (2010). Epidemiology of systemic sclerosis. Best Practice & Research Clinical Rheumatology, 24(6), 857-869.
    DOI Scopus74 WoS64 Europe PMC42
    2010 Nikpour, M., Proudman, S. M., Goh, N. S., & Moutsopoulos, H. M. (2010). Interstitial lung disease in Sjogren's syndrome. Current Rheumatology Reviews, 6(2), 127-137.
    DOI
    2010 Mangat, P., Conron, M., Gabbay, E., & Proudman, S. (2010). Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians. Internal Medicine Journal, 40(7), 494-502.
    DOI Scopus7 WoS6 Europe PMC4
    2009 Lester, S., Proudman, S., Lee, A., Hall, C., McWilliams, L., James, M., & Cleland, L. (2009). Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis. Internal Medicine Journal, 39(5), 296-303.
    DOI Scopus9 WoS8 Europe PMC5
    2009 Cleland, L., James, M., & Proudman, S. (2009). Dietary fats and inflammation: The medicinal use of fish oil. Nutrition & Dietetics, 66(1), 4-6.
    DOI Scopus1 WoS1
    2009 Bejarano, V., Conaghan, P. G., Proudman, S. M., Buch, M. H., Brown, A. K., & Emery, P. (2009). Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis. Annals of the Rheumatic Diseases, 68(5), 761-763.
    DOI Scopus4 Europe PMC3
    2008 Proudman, S., Cleland, L., & James, M. (2008). Dietary omega-3 fats for treatment of inflammatory joint disease: Efficacy and utility. Rheumatic Disease Clinics of North America, 34(2), 469-479.
    DOI Scopus44 WoS45 Europe PMC27
    2008 Cai, F., Lester, S., Lu, T., Keen, H., Boundy, K., Proudman, S., . . . Rischmueller, M. (2008). Mild autonomic dysfunction in primary Sjogren's syndrome: a controlled study. Arthritis Research & Therapy, 10(2), R31-1-R31-10.
    DOI Scopus33 WoS29 Europe PMC18
    2008 James, H., Gillis, D., Hissaria, P., Lester, S., Somogyi, A., Cleland, L., & Proudman, S. (2008). Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis. Journal of Rheumatology, 35(4), 562-571.
    Scopus50 WoS50 Europe PMC37
    2008 Philpott, H., Hissaria, P., Warren, L., Singhal, N., Brown, M., Proudman, S., . . . Gillis, D. (2008). Eosinophilic fasciitis as a paraneoplastic phenomenon associated with metastatic colorectal carcinoma. Australasian Journal of Dermatology, 49(1), 27-29.
    DOI Scopus15 WoS11 Europe PMC3
    2007 Proudman, S., Keen, H., Stamp, L., Lee, A., Goldblatt, F., Ayres, O., . . . Cleland, L. (2007). Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Seminars in Arthritis and Rheumatism, 37(2), 99-111.
    DOI Scopus54 WoS58 Europe PMC42
    2007 Haugeberg, G., Green, M. J., Conaghan, P. G., Quinn, M., Wakefield, R., Proudman, S. M., . . . Emery, P. (2007). Hand bone densitometry: A more sensitive standard for the assessment of early bone damage in rheumatoid arthritis. Annals of the Rheumatic Diseases, 66(11), 1513-1517.
    DOI Scopus35 WoS30 Europe PMC22
    2007 Cox, S. R., McWilliams, L., Massy-Westropp, N., Meads, D. M., McKenna, S. P., & Proudman, S. (2007). Adaptation of the RAQoL for use in Australia. Rheumatology International, 27(7), 661-666.
    DOI Scopus12 WoS14 Europe PMC8
    2007 Marzo-Ortega, H., Green, M. J., Keenan, A. M., Wakefield, R. J., Proudman, S., & Emery, P. (2007). A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis. Arthritis Care and Research, 57(1), 154-160.
    DOI Scopus24 WoS23 Europe PMC21
    2007 Proudman, S., Cleland, L., & James, M. (2007). Omega-3 fatty acids for early rheumatoid arthritis. Medicine Today, 8(12), 57-59.
    2007 Proudman, S., Stevens, W., Sahhar, J., & Celermajer, D. (2007). Pulmonary arterial hypertension in systemic sclerosis: The need for early detection and treatment. Internal Medicine Journal, 37(7), 485-494.
    DOI Scopus94 WoS93 Europe PMC68
    2006 Cleland, L. G., James, M. J., & Proudman, S. M. (2006). Erratum: Fish oil: What the prescriber needs to know (Arthritis Research and Therapy). Arthritis Research and Therapy, 8(4), 1 page.
    DOI Scopus1 WoS1
    2006 Cleland, L., Caughey, G., James, M., & Proudman, S. (2006). Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. Journal of Rheumatology, 33(10), 1973-1979.
    Scopus86 WoS78 Europe PMC34
    2006 Roberts, L., Cleland, L., Thomas, R., & Proudman, S. (2006). Early combination disease modifying antirheumatic drug treatment for rheumatoid arthritis. Medical Journal of Australia, 184(3), 122-125.
    DOI Scopus17 WoS11 Europe PMC7
    2006 Cleland, L., James, M., & Proudman, S. (2006). Fish oil: what the prescriber needs to know. Arthritis Research & Therapy, 8(1), WWW1-WWW9.
    DOI Scopus93 WoS77 Europe PMC36
    2006 Haugeberg, G., Green, M. J., Quinn, M. A., Marzo-Ortega, H., Proudman, S., Karin, Z., . . . Emery, P. (2006). Hand bone loss in early undifferentiated arthritis: Evaluating bone mineral density loss before the development of rheumatoid arthritis. Annals of the Rheumatic Diseases, 65(6), 736-740.
    DOI Scopus69 Europe PMC49
    2005 Cleland, L., James, M., Keen, H., Danda, D., Caughey, G., & Proudman, S. (2005). Fish oil - an example of an anti-inflammatory food. Asia Pacific Journal of Clinical Nutrition, 14(SUPPL.), 66-71.
    Scopus7
    2005 Cox, S., Walker, J., Coleman, M., Rischmueller, M., Proudman, S., Smith, M., . . . Roberts-Thomson, P. (2005). Isolated pulmonary hypertension in scleroderma. Internal Medicine Journal, 35(1), 28-33.
    DOI Scopus60 WoS57 Europe PMC35
    2005 Broadfoot, A., Gillis, D., & Proudman, S. (2005). Lack of association of antineutrophil cytoplasmic antibodies with joint failure as indicated by joint surgery in rheumatoid arthritis. APLAR Journal of Rheumatology, 8(1), 54-59.
    DOI
    2004 Wakefield, R., Green, M., Marzo-Ortega, H., Conaghan, P., Gibbon, W., McGonagle, D., . . . Emery, P. (2004). Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical disease. Annals of the Rheumatic Diseases, 63(4), 382-385.
    DOI Scopus305 WoS286 Europe PMC178
    2003 Cleland, L., James, M., & Proudman, S. (2003). The role of fish oils in the treatment of rheumatoid arthritis. Drugs, 63(9), 845-853.
    DOI Scopus130 WoS113 Europe PMC65
    2003 Cleland, L., Proudman, S., Hall, C., Stamp, L., McWilliams, L., Wylie, N., . . . James, M. (2003). A Biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids, 38(4), 419-424.
    DOI Scopus19 WoS21 Europe PMC14
    2003 James, M., Proudman, S., & Cleland, L. (2003). Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis. Prostaglandins Leukotrienes and Essential Fatty Acids, 68(6), 399-405.
    DOI Scopus47 WoS42 Europe PMC24
    2003 Quinn, M. A., Green, M. J., Marzo-Ortega, H., Proudman, S., Karim, Z., Wakefield, R. J., . . . Emery, P. (2003). Prognostic Factors in a Large Cohort of Patients With Early Undifferentiated Inflammatory Arthritis After Application of a Structured Management Protocol. Arthritis and Rheumatism, 48(11), 3039-3045.
    DOI Scopus94 Europe PMC50
    2003 Conaghan, P. G., O'Connor, P., McGonagle, D., Astin, P., Wakefield, R. J., Gibbon, W. W., . . . Emery, P. (2003). Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis and Rheumatism, 48(1), 64-71.
    DOI Scopus311 Europe PMC197
    2001 Green, M., Marzo-Ortega, H., Wakefield, R., Astin, P., Proudman, S., Conaghan, P., . . . Emery, P. (2001). Predictors of outcome in patients with oligoarthritis - Results of a protocol of intraarticular corticosteroids to all clinically active joints. Arthritis and Rheumatism, 44(5), 1177-1183.
    DOI Scopus40 WoS38 Europe PMC22
    2001 Cleland, L., Fusco, M., Proudman, S., Wing, S., Spargo, L., & Mayrhofer, G. (2001). Recruitment of mononuclear leucocytes to osteoarthritic human synovial xenografts in the ears of SCID mice. Immunology and Cell Biology, 79(4), 309-319.
    DOI
    2000 Cleland, L., Proudman, S., James, M., & Penglis, P. (2000). The changing treatment of arthritis. Australian Prescriber, 23(2), 26-27.
    DOI Scopus1
    2000 Proudman, S. M., Conaghan, P. G., Richardson, C., Griffiths, B., Green, M. J., Mcgonagle, D., . . . Emery, P. (2000). Treatment of poor-prognosis early rheumatoid arthritis: A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis and Rheumatism, 43(8), 1809-1819.
    DOI Scopus134 Europe PMC62
    1999 Proudman, S., Cleland, L., & Mayrhofer, G. (1999). Effects of TNF-a, IL-1b and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice.. Journal of Rheumatology, 26(9), 1877-1889.
    Scopus24 WoS23 Europe PMC17
    1999 Proudman, S., Cleland, L., & Mayrhofer, G. (1999). Effects of Tumor Necrosis Factor-a, Interleukin 1B, and Activated Peripheral Blood Mononuclear Cells on the Expression of Adhesion Molecules and Recruitment of Leukocytes in Rheumatoid Synovial Xenografts in SCID Mice. Journal of Rheumatology, 26(9, September 1999), 1877-1889.
    1999 Proudman, S., Cleland, L., Fusco, M., & Mayrhofer, G. (1999). Accessible xenografts of human synovium in the subcutaneous tissues of the ears of SCID mice. Immunology and Cell Biology, 77(2, April 1999), 109-120.
    DOI Scopus6 WoS7 Europe PMC4
    1999 Green, M., Marzo-Ortega, H., McGonagle, D., Wakefield, R., Proudman, S., Conaghan, P., . . . Emery, P. (1999). Persistence of mild, early inflammatory arthritis: The importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis and Rheumatism, 42(10), 2184-2188.
    DOI Scopus164 WoS136 Europe PMC78
    1994 Hawkes, J. S., Cleland, L. G., Proudman, S. M., & James, M. J. (1994). The effect of methotrexate on ex vivo lipoxygenase metabolism in neutrophils from patients with rheumatoid arthritis. Journal of Rheumatology, 21(1), 55-58.
    Scopus20 WoS21 Europe PMC15
    1994 Cleland, L., James, M., Proudman, S., Neumann, M., & Gibson, R. (1994). Inhibition of human neutrophil leukotriene B<inf>4</inf> synthesis in essential fatty acid deficiency: Role of leukotriene a hydrolase. Lipids, 29(3), 151-155.
    DOI Scopus18 WoS17 Europe PMC9
    1994 James, M. J., Cleland, L. G., Gaffney, R. D., Proudman, S. M., & Chatterton, B. E. (1994). Effect of exercise on <sup>99m</sup>Tc-DTPA clearance from knees with effusions. Journal of Rheumatology, 21(3), 501-504.
    Scopus23 WoS21 Europe PMC18
    1992 Proudman, S., & Cleland, L. (1992). Auranofin‐induced vasomotor reaction. Arthritis &amp; Rheumatism, 35(12), 1452-1454.
    DOI Scopus4 WoS5 Europe PMC2
    1992 CLELAND, L. G., JAMES, M. J., PROUDMAN, S. M., NEUMANN, M., & GIBSON, R. A. (1992). INHIBITION OF HUMAN NEUTROPHIL LEUKOTRIENE-B4 PRODUCTION BY N-9 EICOSTRIENOIC ACID. ARTHRITIS AND RHEUMATISM, 35(9), S36.

  • Book Chapters
    Year Citation
    2003 Cleland, L., James, M., & Proudman, S. (2003). Omega-6/Omega-3 fatty acids and arthritis. In A. Simopoulos, & L. Cleland (Eds.), Omega-6/Omega-3 essential fatty acid ratio: the scientific evidence (Vol. 92, pp. 152-168). PO Box, CH-4009 Basel, Switzerland: S Karger AG.
    DOI Scopus19 Europe PMC6

  • Conference Papers
    Year Citation
    2021 He, J., Sunny, L., Sallis, O., McWilliams, L., Spargo, L., Metcalf, R., . . . Proudman, S. (2021). PULMONARY FUNCTION ABNORMALITIES IN RHEUMATOID ARTHRITIS, TO SCREEN OR NOT TO SCREEN?. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 39). WILEY.
    2021 Small, A., Williams, K., Song, Q., Hao, L. -Y., Murray-Brown, W., Proudman, S., . . . Wechalekar, M. D. (2021). PROGRAMMED DEATH 1 (PD-1)-EXPRESSING T CELLS ARE PATHOGENIC IN EARLY RHEUMATOID ARTHRITIS AND CORRELATE WITH RESPONSE TO TREATMENT. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 6-7). WILEY.
    2021 Black, R., Lester, S., Tieu, J., Sinnathurai, P., Barrett, C., Buchbinder, R., . . . Hill, C. L. (2021). MORTALITY ASSOCIATED WITH RHEUMATOID ARTHRITIS IN AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE PARTICIPANTS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 37-38). WILEY.
    2021 Sallis, O., Hansen, D., Morrisroe, K., Stevens, W., Nikpour, M., & Proudman, S. (2021). THE USE OF LIPID-LOWERING AGENTS IN SYSTEMIC SCLEROSIS: IS THERE A RELATIONSHIP WITH PREVALENCE OF DIGITAL ULCERS AND OVERALL SURVIVAL?. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 37). WILEY.
    2020 Small, A., Murray-Brown, W., Guo, Y., Weedon, H., Proudman, S., Smith, M., . . . Wechalekar, M. (2020). CHARACTERISATION OF PROGRAMMED CELL DEATH PROTEIN 1 EXPRESSING PERIPHERAL T HELPER CELLS IN THE EARLY RHEUMATOID ARTHRITIS SYNOVIUM. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 42-43). WILEY.
    2019 Valenzuela, A., Chung, M., Rodriguez-Reyna, T. S., Proudman, S., Baron, M., Castelino, F., . . . Chung, L. (2019). Change in Calcinosis over 1 Year Using the SCTC Radiologic Scoring System for Calcinosis of the Hands in Patients with Systemic Sclerosis. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 3 pages). WILEY.
    WoS1
    2018 Boulos, D., Metcalf, R., Proudman, S., & Wicks, I. (2018). The Neutrophil-Lymphocyte Ratio in Newly Diagnosed Rheumatoid Arthritis and Its Ability to Predict Treatment Failure. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 1 page). WILEY.
    2018 Day, J., Otto, S., Cash, K., Eldi, P., Hissaria, P., Proudman, S., . . . Limaye, V. (2018). Aberrant Sarcoplasmic Expression of the Alarmin 'High Mobility Group Box Protein 1 '' (HMGB1) in Patients with Idiopathic Inflammatory Myopathy. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). WILEY.
    2018 Reid, A., Wiese, M. D., Metcalf, R., Wechalekar, M. D., Lee, A., Hill, C., . . . Proudman, S. (2018). Utility of Serial ACPA Measurements in Rheumatoid Arthritis: Results of a Prospective Cohort Study. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). WILEY.
    2016 Guo, Y., Walsh, A., Fearon, U., Smith, M. D., Wechalekar, M. D., Yin, X., . . . Nagpal, S. (2016). Gene Enrichment Analysis Identifies Active CD40-CD40L Signaling in Early and Established Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 1 page). WILEY.
    2016 Morrisroe, K., Huq, M., Stevens, W., Sahhar, J., Proudman, S., & Nikpour, M. (2016). Work Productivity in Systemic Sclerosis and Association with Health Related Quality of Life. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 3 pages). WILEY.
    WoS2
    2016 Wechalekar, M. D., Lester, S., Nagpal, S., Peters, J., Dash, A., Hissaria, P., . . . Proudman, S. M. (2016). Seropositivity Predicts Bone Biomarker Change in an Inception Cohort of Rheumatoid Arthritis Patients Treated-to-Target with Combination Conventional DMARD Therapy. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). WILEY.
    2016 Valenzuela, A., Gordon, J. K., Sofia Rodriguez-Reyna, T., Proudman, S., Baron, M., Hinchcliff, M., . . . Chung, L. (2016). Comprehensive Characterization of Calcinosis in a Multicenter International Cohort of Patients with Systemic Sclerosis. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). WILEY.
    2016 Khanna, D., Proudman, S., Frech, T. M., Nihtyanova, S., Domsic, R. T., Berrocal, V. J., . . . Denton, C. P. (2016). Performance of Modified Rodnan Skin Score in Early Diffuse Cutaneous Scleroderma-Analysis from 4 International Cohorts. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 3 pages). WILEY.
    2011 Patterson, K., Sakko, A., Ricciardelli, C., Proudman, S., & Hissaria, P. (2011). EVALUATION OF ANGIOGENIC AND FIBROGENIC CYTOKINES AS BIOMARKERS IN SUBGROUPS OF SYSTEMIC SCLEROSIS. In INTERNAL MEDICINE JOURNAL Vol. 41 (pp. 9-10). WILEY-BLACKWELL.
    2011 Hill, C. L., Jones, G., March, L., Battersby, R., Hynes, K., Fedorova, T., . . . Cleland, L. G. (2011). Fish Oil in Knee Osteoarthritis: A Two Year Randomized, Double-Blind Clinical Trial Comparing High Dose with Low Dose. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S426). Chicago, IL: WILEY.
    2011 Ngian, G. -S., Stevens, W., Byron, J., Ai, T., Roddy, J. E., Minson, R., . . . Nikpour, M. (2011). Survival and Predictors of Mortality In Australian Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S332). Chicago, IL: WILEY.
    WoS1
    2010 James, M., Proudman, S., & Cleland, L. (2010). Fish oil and rheumatoid arthritis: past, present and future. In Proceedings of the 3rd International Immunonutrition Workshop Vol. 69 (pp. 316-323). UK: Cambridge University Press.
    DOI Scopus61 WoS54 Europe PMC37
    2007 Cleland, L., Caughey, G., Proudman, S., James, M., & Lee, A. (2007). Fish oil treatment and cardiovascular risk in early rheumatoid arthritis. In ANNALS OF THE RHEUMATIC DISEASES Vol. 66 (pp. 347). Barcelona, SPAIN: B M J PUBLISHING GROUP.
    WoS1
    2007 Lee, X., Proudman, S., Phillips, M., Slavotinek, J., & Cleland, L. (2007). High resolution musculoskeletal sonography in early arthritis: Can we predict outcome?. In ANNALS OF THE RHEUMATIC DISEASES Vol. 66 (pp. 94). Barcelona, SPAIN: B M J PUBLISHING GROUP.
    2006 James, H., Gillis, D., Hissaria, P., Lester, S., Somogyi, A., Cleland, L., & Proudman, S. (2006). Polymorphisms in the folate pathway predict response to methotrexate in early RA.. In ARTHRITIS AND RHEUMATISM Vol. 54 (pp. S129). Washington, DC: WILEY-LISS.
    2005 Marzo-Ortega, H., Green, M., Keenan, A., Wakefield, R., Proudman, S., & Emery, P. (2005). A randomised trial of intra-articular corticosteroids versus conservative treatment in early oligoarthritis over 12 months. In RHEUMATOLOGY Vol. 44 (pp. I90). Birmingham, ENGLAND: OXFORD UNIV PRESS.
    2004 Marzo-Ortega, H., Green, M., Keenan, A., Wakefield, R., Proudman, S., & Emery, P. (2004). A randomised trial of intra-articular corticosteroids versus conservative treatment in early oligoarthritis over 12 months. In ARTHRITIS AND RHEUMATISM Vol. 50 (pp. S130-S131). San Antonio, TX: WILEY-LISS.
    WoS1
    2004 Proudman, S. (2004). Tracleer (bosentan), a dual endothelin receptor antagonist (ERA), for the treatment of pulmonary arterial hypertension (PAH) related to connective tissue diseases: Effect on quality of life (QoL). In ARTHRITIS AND RHEUMATISM Vol. 50 (pp. S692). San Antonio, TX: WILEY-LISS.
    1999 Emery, P., Marzo, H., & Proudman, S. (1999). Management of patients with newly diagnosed rheumatoid arthritis. In Rheumatology Vol. 38 (pp. 27-31). England.
    Scopus27 Europe PMC7
    1998 Proudman, S. (1998). Aggressive combination therapy provides clinical improvement for RA. In Geriatrics Vol. 53 (pp. 67-68).

  • Conference Items
    Year Citation
    2020 Abuhelwa, A., Manning-Bennett, A., Hopkins, A., Sorich, M., Proudman, S., Foster, D., & Wiese, M. (2020). ASSOCIATION OF BETA-BLOCKER USE AND DISEASE REMISSION IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A RETROSPECTIVE MULTICOHORT ANALYSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2020 Abuhelwa, A., Daraghmeh, M. D., Hopkins, A., Sorich, M., Wechalekar, M., Proudman, S., . . . Wiese, M. (2020). ASSOCIATION OF CONCOMITANT METFORMIN USE AND REMISSION OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: A RETROSPECTIVE MULTICOHORT ANALYSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2020 Fairley, J., Hansen, M. D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2020). CLINICAL CHARACTERISTICS AND SURVIVAL IN SYSTEMIC SCLEROSIS-MIXED CONNECTIVE TISSUE DISEASE AND SYSTEMIC SCLEROSIS-OVERLAP SYNDROME. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2020 Abuhelwa, A., Hopkins, A., Sorich, M., Proudman, S., Foster, D., & Wiese, M. (2020). OBESITY DECREASES THE CHANCE OF ACHIEVING REMISSION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: A RETROSPECTIVE MULTICOHORT ANALYSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2019 Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2019). Clinical Characteristics and Survival in Systemic Sclerosis-mixed Connective Tissue Disease and Systemic Sclerosis-overlap Syndrome. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2019 Hong, L. E., Singhal, D., Wee, A., Chhetri, R., Kutyna, M., Wechalekar, M., . . . Proudman, S. (2019). MUTATIONAL LANDSCAPE OF MYELODYSPLASTIC SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATOLOGICAL DISORDERS. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
    DOI
    2019 Murray-Brown, W., Guo, Y., Wechalekar, M., Weedon, H., Smith, M., Proudman, S., . . . Wechalekar, M. (2019). Expanded Peripheral T Helper Cells Characterize the Early Rheumatoid Arthritis Synovium. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2019 Brown, Z., Metcalf, R., Bednarz, J., Stavrou, C., Spargo, L., James, M., & Proudman, S. (2019). Modifiable Factors Associated with Response to Treatment in Early Rheumatoid Arthritis. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. United States: WILEY.
    DOI Europe PMC1
    2018 Moxey, J., Huq, M., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2018). Significance of Anti-Neutrophil Cytoplasmic Antibodies in Systemic Sclerosis. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2018 March, L., Willers, C., Ellis, J., Cobb, J., Lester, S., Buchbinder, R., . . . Murray, K. (2018). THE AUSTRALIAN ARTHRITIS AND AUTOIMMUNE BIOBANK COLLABORATIVE (A3BC) PROTOCOL. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2018 Ross, L., Patel, S., Stevens, W., Rabusa, C., Wilson, M., Ferdowsi, N., . . . Nikpour, M. (2018). ECHOCARDIOGRAPHY IN DETECTION OF PRIMARY SYSTEMIC SCLEROSIS CARDIAC DISEASE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2018 Boulos, D., Metcalf, R., Proudman, S., & Wicks, I. (2018). THE NEUTROPHIL-LYMPHOCYTE RATIO IN NEWLY DIAGNOSED RHEUMATOID ARTHRITIS AND ITS ABILITY TO PREDICT TREATMENT FAILURE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2018 Ross, L., Stevens, W., Rabusa, C., Wilson, M., Ferdowsi, N., Walker, J., . . . Nikpour, M. (2018). THE ROLE OF INFLAMMATORY MARKERS IN ASSESSMENT OF DISEASE ACTIVITY IN SYSTEMIC SCLEROSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2018 Reid, A., & Proudman, S. (2018). REPEAT SEROLOGICAL TESTING FOR ANTI-CITRULLINATED PEPTIDE ANTIBODY AFTER COMMENCEMENT OF THERAPY IS NOT HELPFUL IN PATIENTS WITH SERONEGATIVE RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2018 Hong, L. E., Singhal, D., Wee, A., Chhetri, R., Wechalekar, M. D., Proudman, S., & Hiwase, D. K. (2018). The Mutation Profile of Myelodysplastic Syndrome Associated with Auto-Immune Rheumatological Disorders. Poster session presented at the meeting of BLOOD. San Diego, CA: AMER SOC HEMATOLOGY.
    DOI
    2018 Cole, S., Walsh, A., Yin, X., Wechalekar, M., Smith, M., Proudman, S. M., . . . Guo, Y. (2018). Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich rheumatoid arthritis, pre-rheumatoid arthritis and systemic lupus erythematosus. Poster session presented at the meeting of JOURNAL OF IMMUNOLOGY. Austin, TX: AMER ASSOC IMMUNOLOGISTS.
    2017 Day, J., Limaye, V., Hayball, J., Proudman, S., & Hissaria, P. (2017). PREDICTORS OF TREATMENT RESPONSE AND DISEASE RELAPSE IN RHEUMATOLOGY PATIENTS TREATED WITH RITUXIMAB: A SINGLE CENTRE RETROSPECTIVE COHORT STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2017 Whittle, S., Menz, F., Lester, S., Proudman, S., & Hill, C. (2017). THE DAS28-P INDEX AS A PREDICTOR OF POOR SUBJECTIVE RESPONSE TO DMARD THERAPY IN EARLY RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    WoS1
    2017 Chow, K. V. C., Lester, S., McWilliams, L., Metcalf, R., Lee, A., Wechalekar, M., . . . Proudman, S. (2017). SUPPLEMENTATION WITH OMEGA-3 FISH OIL HAS NO EFFECT ON BONE MINERAL DENSITY IN RHEUMATOID ARTHRITIS: A 3-YEAR RANDOMIZED CONTROLLED TRIAL. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2017 Ruediger, C., Nguyen, L., Black, R., Proudman, S., & Hill, C. (2017). A REVIEW OF METHOTREXATE USE IN POLYMYALGIA RHEUMATICA (PMR). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY.
    2017 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. (2017). Anti-Topoisomerase Antibodies Are Negatively Associated with Smoking in Systemic Sclerosis. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Ottawa, CANADA: J RHEUMATOL PUBL CO.
    2017 Walker, J. G., Nikpour, M., Huq, M., Patterson, K., Roberts-Thomson, P., Proudman, S., . . . Fritzler, M. J. (2017). Autoantibodies to the hPOP1 and Rpp25/38 Components of the Th/to Complex Identify a Subgroup of Systemic Sclerosis (SSc) Associated Interstitial Lung Disease (ILD) and Antibodies to hPOP1 Are Associated with Reduced Survival. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2017 Wiese, M. D., Metcalf, R., Wechalekar, M. D., Spargo, L., McWilliams, L., James, M., . . . Proudman, S. (2017). Predicting Remission at 6 Months in Early Rheumatoid Arthritis Treated with Conventional Synthetic Dmards. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2017 Bhushan, V., Maundrell, A., Proudman, C., McWilliams, L., Spargo, L., Metcalf, R., . . . Proudman, S. (2017). Application of a Diagnostic Algorithm to Identify Inflammatory Myopathy in Systemic Sclerosis. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2017 McMahan, Z., Frech, T. M., Lim, D., Berrocal, V. J., Bruni, C., Matucci-Cerinic, M., . . . Khanna, D. (2017). Evaluation of Validated Patient Reported Outcome Measures to Assess Sensitivity to Change in Patients with Systemic Sclerosis and Gastroesophageal Reflux Disease -a Scleroderma Clinical Trials Consortium Collaborative Project. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2017 Wechalekar, M. D., Lester, S., Nagpal, S., Cole, S., Peters, J., Das, A., . . . Proudman, S. (2017). Osteopontin and Leptin Are Associated with Erosive Disease in an Inception Cohort of Rheumatoid Arthritis Treated-to-Target with Combination Conventional DMARD Therapy. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2017 Walsh, A. M., Canavan, M., Guo, Y., McGarry, T., Yin, X., Wechalekar, M. D., . . . Nagpal, S. (2017). IMMUNE SIGNAL 2 CHECKPOINT MOLECULE EXPRESSION IN RHEUMATOID ARTHRITIS DISEASE PROGRESSION. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP.
    DOI
    2016 Wechalekar, M. D., Lester, S., Nagpal, S., Cole, S., Das, A., Hissaria, P., . . . Proudman, S. M. (2016). RANKL, OPG AND OSCAR BUT NOT DKK-1 PREDICT RADIOGRAPHIC PROGRESSION IN AN INCEPTION COHORT OF SEROPOSITIVE RHEUMATOID ARTHRITIS (RA) TREATED-TO-TARGET WITH COMBINATION CONVENTIONAL DMARD THERAPY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. London, ENGLAND: BMJ PUBLISHING GROUP.
    DOI WoS2
    2016 Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Proudman, S., & Nikpour, M. (2016). Determinants of unemployment amongst Australian systemic sclerosis patients. Poster session presented at the meeting of Abstracts, as published in Annals of the Rheumatic Diseases. London: BMJ Publishing Group.
    DOI
    2016 Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Proudman, S., & Nikpour, M. (2016). Risk factors for development of pulmonary arterial hypertension in Australian scleroderma patients. Poster session presented at the meeting of Abstracts, as published in Annals of the Rheumatic Diseases. London: BMJ Publishing Group.
    DOI
    2016 Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Proudman, S., & Nikpour, M. (2016). SURVIVAL IN SYSTEMIC SCLEROSIS RELATED PULMONARY ARTERIAL HYPERTENSION IN THE MODERN TREATMENT ERA: RESULTS FROM A MULTICENTRE AUSTRALIAN COHORT STUDY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. London, ENGLAND: BMJ PUBLISHING GROUP.
    DOI
    2016 Boulos, D., Rajadurai, A., Ngian, G. S., Elford, K., Stevens, W., Proudman, S., . . . Sahhar, J. (2016). LONG-TERM EFFICACY AND TOLERABILITY OF MYCOPHENOLATE MOFETIL THERAPY IN DIFFUSE SCLERODERMA SKIN DISEASE. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. London, ENGLAND: BMJ PUBLISHING GROUP.
    DOI
    2016 McMahan, Z., Frech, T. M., Piemonte, G., Matucci-Cerinic, M., Proudman, S., Berrocal, V. J., . . . Khanna, D. (2016). Preliminary Evaluation of Gastroesophageal Reflex Disease Outcome Measures in Scleroderma- Scleroderma Clinical Trials Consortium Gastrointestinal Working Group. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    WoS1
    2016 Morrisroe, K., Huq, M., Stevens, W., Rabusa, C., Sahhar, J., Ngian, G., . . . Nikpour, M. (2016). Survival and Health-Related Quality of Life in Incident Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Multicentre Australian Cohort Study. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. WILEY.
    2016 Morrisroe, K., Hug, M., Stevens, W., Rabusa, C., Proudman, S., Nikpouri, M., & Asig. (2016). DETERMINANTS OF UNEMPLOYMENT AMONGST AUSTRALIAN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A MULTICENTRE COHORT STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2016 Morrisroe, K., Hug, M., Stevens, W., Rabusa, C., Proudman, S., Nikpouri, M., & Asig. (2016). RISK FACTORS FOR DEVELOPMENT OF PULMONARY ARTERIAL HYPERTENSION IN AUSTRALIAN SCLERODERMA PATIENTS: RESULTS FROM A LARGE MULTICENTER COHORT STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Hissaria, P., Bert, A., Proudman, S., Goodall, G., & Khew-Goodall, Y. (2015). DIFFERENTIAL PATTERN OF MICRORNA EXPRESSION IN LIMITED AND DIFFUSE CUTANEOUS VARIANTS OF SYSTEMIC SCLEROSIS - A POSSIBLE MECHANISM TO EXPLAIN THE UNIQUE CLINICAL PHENOTYPES. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Maundrell, A., Chaudhary, S., Blumbergs, P., Proudman, S., & Limaye, V. (2015). IDIOPATHIC INFLAMMATORY MYOSITIS IS ASSOCIATED WITH SYSTEMIC SCLEROSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Wojciechowski, J., Wiese, M., Proudman, S., Foster, D., & Upton, R. (2015). A SYSTEMATIC EVALUATION OF SINGLE MEASURES IN DISCRIMINATING CHANGES IN RHEUMATOID ARTHRITIS DISEASE ACTIVITY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Murthy, S., Lester, S., Limaye, V., Goldblatt, F., McWilliams, L., Nikpour, M., . . . Proudman, S. (2015). VALIDATION OF THE 2013 ACR/EULAR CLASSIFICATION CRITERIA FOR SYSTEMIC SCLEROSIS IN AUSTRALIAN PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    WoS1
    2015 Rajadurai, A., Ngian, G., Elford, K., Stevens, W., Proudman, S., Roddy, J., . . . Sahhar, J. (2015). MYCOPHENOLATE MOFETIL IN THE TREATMENT OF SCLERODERMA-ASSOCIATED DIFFUSE SKIN DISEASE: RESULTS FROM THE AUSTRALIAN SCLERODERMA COHORT STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Hopkins, A., Proudman, S., Vitry, A., Sorich, M., Cleland, L., & Wiese, M. (2015). WHAT HAVE WE LEARNT FROM 10 YEARS OF BIOLOGICAL DISEASE MODIFYING AGENTS ON THE PHARMACEUTICAL BENEFIT SCHEME?. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Ferdowsi, N., Tay, T., Baron, M., Stevens, W., Hudson, M., Sundararajan, V., . . . Nikpour, M. (2015). DEVELOPMENT OF A DISEASE DAMAGE INDEX IN SYSTEMIC SCLEROSIS: SURVEY OF EXPERTS AND ITEM REDUCTION USING RASCH MODELLING. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Esposito, J., Stevens, W., Rabusa, C., Sahhar, J., Walker, J., Thakkar, V., . . . Nikpour, M. (2015). THE ASSOCIATION OF HYPOCOMPLEMENTEMIA WITH DISEASE ACTIVITY IN SYSTEMIC SCLEROSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Hopkins, A., Wiese, M., O'Doherty, C., & Proudman, S. (2015). Putting recommendations into practice: Australian rheumatologists’ opinions on leflunomide use in rheumatoid arthritis. Poster session presented at the meeting of Abstracts from the Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association 56th Annual Scientific Meeting, as published in Internal Medicine Journal. Adelaide, South Australia: Wiley-Blackwell.
    DOI
    2015 Foreman, C., Russo, P., Davies, N., Hissaria, P., Hughes, T., Proudman, S., & Limaye, V. (2015). AN AUDIT OF IVIG USE FOR INFLAMMATORY MYOPATHIES IN SOUTH AUSTRALIA. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Wechalekar, M., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). FOOT SYNOVITIS IN PATIENTS IN APPARENT REMISSION IS ASSOCIATED WITH WORSE LONG-TERM FUNCTIONAL OUTCOMES. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Tay, T., Ferdowsi, N., Baron, M., Stevens, W., Hudson, M., Proudman, S., & Nikpour, M. (2015). Measures of disease status in systemic sclerosis: systematic review. Poster session presented at the meeting of Abstracts of the Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, as published in Internal Medicine Journal. Adelaide, South Australia: Wiley.
    DOI
    2015 Proudman, S., Nikpour, M., & Stevens, W. (2015). CHANGES IN RHEUMATOLOGISTS' SCREENING PRACTICES FOR PULMONARY ARTERIAL HYPERTENSION AND INTERSTITIAL LUNG DISEASE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. (2015). Clinical Correlates of Monospecific Anti-Ro52/TRIM21 Antibodies in a Tri-nation Cohort of 1574 Systemic Sclerosis Subjects. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Quebec, CANADA: J RHEUMATOL PUBL CO.
    2015 Hissaria, P., Bert, A., Proudman, S., Goodall, G., & Khew-Goodall, Y. (2015). MICRO RNAS (MIRNAS) INVOLVED IN TGF BETA SIGNALLING PATHWAYS ARE DIFFERENTIALLY EXPRESSED IN THE PAPILLARY DERMIS OF INVOLVED SKIN IN LIMITED AND DIFFUSE CUTANEOUS SCLERODERMA PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2015 Foreman, C., Russo, P., Davies, N., Hissaria, P., Hughes, T., Proudman, S., & Limaye, V. (2015). AN AUDIT OF IVIG USE FOR INFLAMMATORY MYOPATHIES IN SOUTH AUSTRALIA. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2014 Khanna, D., Berrocal, V., Giannini, E., Mayes, M., Merkel, P., Siegel, J., . . . Furst, D. (2014). Development of a composite index for clinical trials in early diffuse cutaneous systemic sclerosis - the combined response index in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 2014 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Boston, MA: Wiley-Blackwell.
    DOI
    2014 Wechalekar, M., Quinn, S., Lester, S., Shanahan, E., Metcalf, R., Shanahan, E., & Proudman, S. (2014). A treat-to-target strategy preserves work capacity in early rheumatoid arthritis (RA). Poster session presented at the meeting of Abstracts of the 2014 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Boston, MA: Wiley-Blackwell.
    DOI
    2014 Osthoff, M., Ngian, G., Dean, M., Nikpour, M., Stevens, W., Proudman, S., . . . Sahhar, J. (2014). The lectin pathway of complement - a potential role in the pathogenesis and disease manifestations of systemic sclerosis. Poster session presented at the meeting of Abstracts of the 2014 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Boston, MA: Wiley-Blackwell.
    DOI
    2014 Owen, C., Ngian, G., Elford, K., Moore, O., Nikpour, M., Stevens, W., . . . Sahhar, J. (2014). Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study. Poster session presented at the meeting of Abstracts of the 2014 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Boston, MA: Wiley-Blackwell.
    DOI
    2014 Hao, Y., Hudson, M., Carreira, P., Stevens, W., Rabusa, C., Tatibouet, S., . . . Nikpour, M. (2014). Early mortality in Australian, Canadian and Spanish scleroderma patients: rationale for establishing a multi-national inception cohort of patients with systemic sclerosis. Poster session presented at the meeting of Abstracts of the 2014 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Boston, MA: Wiley-Blackwell.
    DOI WoS2
    2014 Tien, T., Ferdowsi, N., Stevens, W., Hudson, M., Baron, M., Rabusa, C., . . . Nikpour, M. (2014). Measures of disease status in systemic sclerosis: systematic review. Poster session presented at the meeting of Abstracts of the 2014 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Boston, MA: Wiley-Blackwell.
    DOI
    2014 Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2014). A COMPARISON OF THE PREDICTIVE ACCURACY OF THREE SCREENING MODELS (DETECT V. ESC/ERS V. ASIG) FOR PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC SCLEROSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. Hobart, Tasmania: WILEY-BLACKWELL.
    2014 Goh, N., Corte, T., Moore, O., Rouse, H., Hennessy, O., Thakkar, V., . . . Nikpour, M. (2014). Serial Change In Pfts Is Predictive Of Outcome In Systemic Sclerosis Associated Interstitial Lung Disease. Poster session presented at the meeting of AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC.
    2014 Hao, Y. J., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). A comparison of the predictive accuracy of three screening models (DETECT v.ESC/ERS v. ASIG) for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology.
    2014 Foreman, C., Sahhar, J., Ngian, G., Briggs, N., Spargo, L., Kathleen, E., . . . Proudman, S. (2014). Vitamin D in systemic sclerosis (SSc): prevalence and associations of vitamin D deficiency in patients from two centres of the Australian Scleroderma Cohort Study (ASCS). Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
    DOI
    2014 Quinlivan, A., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology.
    2014 Proudman, S., Cleland, L., Lee, A., Wechalekar, M., Metcalf, R., Sullivan, T., . . . James, M. (2014). Relationship between plasma omega-3 fatty acids and clinical outcomes in recent onset rheumatoid arthritis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
    DOI
    2014 Tay, T., Stevens, W., Baron, M., Hudson, M., Rabusa, C., Prior, D., . . . Nikpour, M. (2014). Early accrual of organ damage in scleroderma: rationale for derivation and validation of a disease damage index in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology.
    2014 Nikpour, M., Hudson, M., Stevens, W., Rabusa, C., Tatibouet, S., Proudman, S., & Baron, M. (2014). Early mortality in Australian and Canadian scleroderma patients: rationale for establishing a multi-national inception cohort of patients with systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology.
    WoS3
    2014 Quinlivan, A., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
    DOI
    2014 Lester, S., Patterson, K., Walker, J., Charlesworth, J., Stankovich, J., Stevens, W., . . . Zochling, J. (2014). Associations between HLA DRB1 alleles and autoantibodies in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
    DOI
    2014 Wiese, M., Hopkins, A., Spargo, L., McWilliams, L., O'Doherty, C., Cleland, L., & Proudman, S. (2014). A pilot study to assess the impact of patient, genetic and disease factors on response to the disease modifying anti-rheumatic drug leflunomide. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
    DOI
    2014 Owen, C., Ngian, G., Moore, O., Stevens, W., Proudman, S., Roddy, J., . . . Sahhar, J. (2014). Mycophenolate mofetil versus azathioprine in scleroderma-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
    DOI
    2014 Patterson, K., Roberts-Thomson, P., Lester, S., Proudman, S., Rischmueller, M., Stevens, W., . . . Walker, J. (2014). Autoantibody associations among a well-characterized Australian systemic sclerosis (SSc) cohort. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
    DOI
    2014 Wechalekar, M., Lester, S., Hill, C., Shanahan, E., Metcalf, R., Shanahan, M., & Proudman, S. (2014). Work disability in an inception cohort of early rheumatoid arthritis (RA) receiving treat-to-target therapy. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell.
    DOI
    2013 Thakkar, V., Stevens, W., Prior, D., Sahhar, J., Roddy, J., Zochling, J., . . . Nikpour, M. (2013). Asymmetric dimethylarginine levels in the early detection of systemic sclerosis-related pulmonary arterial hypertension. Poster session presented at the meeting of Abstracts of the 2013 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. San Diego, CA: Wiley-Blackwell.
    DOI WoS1
    2013 Moore, O., Proudman, S., Goh, N., Corte, T., Rouse, H., Hennessy, O., . . . Nikpour, M. (2013). Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Poster session presented at the meeting of Abstracts of the 2013 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. San Diego, CA: Wiley-Blackwell.
    DOI WoS1 Europe PMC16
    2013 Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Patterson, K., . . . Australian Scleroderma Interest Group. (2013). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 2012 Annual European Congress of Rheumatology, as published in Annals of the Rheumatic Diseases. Berlin, Germany: BMJ Publishing Group.
    DOI
    2013 Nikpour, M., Baron, M., Hudson, M., Carreira, P., Hunzelmann, N., Frech, T., . . . Proudman, S. (2013). Early accrual of organ damage in systemic sclerosis: rationale for forming a multinational inception cohort of patients with scleroderma (The Insync Study). Poster session presented at the meeting of Abstracts of the 2013 Annual European Congress of Rheumatology, as published in Annals of the Rheumatic Diseases. Madrid, Spain: BMJ Publishing Group.
    DOI WoS1
    2013 Thakkar, V., Stevens, W., Prior, D., Roddy, J., Zochling, J., Sahhar, J., . . . Nikpour, M. (2013). Assymetric dimethylarginine (ADMA) levels in the early detection of systemic sclerosis related pulmonary arterial hypertension (SSc-PAH). Poster session presented at the meeting of Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association 54th Annual Scientific Meeting, as published in Internal Medicine Journal. Perth, W.A.: Wiley-Blackwell.
    DOI
    2013 Nikpour, M., Proudman, S., Zochling, J., Sahhar, J., Nash, P., Youssef, P., . . . Stevens, W. (2013). Early mortality in systemic sclerosis: rationale for forming a multinational inception cohort of patients with scleroderma (the Insync Study). Poster session presented at the meeting of Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association 54th Annual Scientific Meeting, as published in Internal Medicine Journal. Perth, W.A.: Wiley-Blackwell.
    DOI
    2013 Nikpour, M., Stevens, W., Roddy, J., Zochling, J., Sahhar, J., Walker, J., . . . Proudman, S. (2013). Early accrual of organ damage in systemic sclerosis: rationale for forming a multinational inception cohort of patients with scleroderma (the INSYNC Study). Poster session presented at the meeting of Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association 54th Annual Scientific Meeting, as published in Internal Medicine Journal. Perth, W.A.: Wiley-Blackwell.
    DOI
    2013 Nikpour, M., Baron, M., Hudson, M., Carreira, P., Hunzelmann, N., Frech, T., . . . Stevens, W. (2013). Early mortality in systemic sclerosis: rationale for forming a multinational inception cohort of patients with scleroderma (the INSYNC Study). Poster session presented at the meeting of Abstracts of the 2013 Annual European Congress of Rheumatology, as published in Annals of the Rheumatic Diseases. Madrid, Spain: BMJ Publishing Group.
    DOI
    2013 Morrisroe, K. B., Stevens, W. M., Byron, J., Thakkar, V., Moore, O., Proudman, S., . . . Australian Scleroderma Interest Group. (2013). Anti-phospholipid antibodies in systemic sclerosis: prevalence and clinical correlations. Poster session presented at the meeting of Abstracts of the 2012 Annual European Congress of Rheumatology, as published in Annals of the Rheumatic Diseases. Berlin, Germany: BMJ Publishing Group.
    DOI WoS1
    2013 Charlesworth, J., Stankovich, J., Lewis, P., Byron, J., Stevens, W., Sahhar, J., . . . Zochling, J. (2013). An immunochip based interrogation of scleroderma susceptibility variants. Poster session presented at the meeting of Abstracts of the 2012 Annual European Congress of Rheumatology, as published in Annals of the Rheumatic Diseases. Berlin, Germany: BMJ Publishing Group.
    DOI
    2013 Wiese, M., Alotabi, N., O'Doherty, C., Sorich, M., Suppiah, V., Cleland, L., & Proudman, S. (2013). Variability in genes that encode N-acetyl transferase 2 and ABCG2 and disease outcomes in early rheumatoid arthritis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with the Rheumatology Health Professionals Association 54th Annual Scientific Meeting, as published in Internal Medicine Journal. Perth, W.A.: Wiley-Blackwell.
    DOI
    2013 Hill, C., Jones, G., Lester, S., Battersby, R., Fedorova, T., Hynes, K., . . . March, L. (2013). Effect of fish oil on structural progression in knee osteoarthritis: a two year randomized, double-blind clinical trial comparing high dose with low dose. Poster session presented at the meeting of Abstracts of the 2013 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. San Diego, CA: Wiley-Blackwell.
    DOI WoS1
    2013 Moore, O. A., Goh, N., Corte, T., Rouse, H., Hennessy, O., Thakkar, V., . . . Australian Scleroderma Interest Group. (2013). Identifying and quantifying prognostic factors in systemic sclerosis-related interstitial lung disease using a time-varying covariate survival model. Poster session presented at the meeting of Abstracts of the 2012 Annual European Congress of Rheumatology, as published in Annals of the Rheumatic Diseases. Berlin, Germany: BMJ Publishing Group.
    DOI
    2013 Saketkoo, L., Mittoo, S., Huscher, D., Dellaripa, P., Denton, C., Distler, O., . . . Brown, K. K. (2013). Provisional Consensus On Domains And Instruments In Connective Tissue Disease Related Interstitial Lung Disease And Idiopathic Pulmonary Fibrosis For Use In Clinical Trials. Poster session presented at the meeting of AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. AMER THORACIC SOC.
    2012 Moore, O. A., Goh, N., Corte, T., Rouse, H., Hennessy, O., Thakkar, V., . . . Australian Scleroderma Interest Group. (2012). Extent of disease on high-resolution CT lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Poster session presented at the meeting of Abstracts of the 2013 Annual European Congress of Rheumatology, as published in Annals of the Rheumatic Diseases. Madrid, Spain: BMJ Publishing Group.
    DOI
    2012 Chaudhary, S. H., Proudman, S., & Limaye, V. S. (2012). Idiopathic inflammatory myositis is associated with an increased incidence of systemic sclerosis. Poster session presented at the meeting of Abstracts of the 2012 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Washington, D.C.: Wiley-Blackwell.
    DOI WoS1
    2012 Black, R., Spargo, L., Shultz, C., Chatteron, B., James, M., Cleland, L., . . . Proudman, S. (2012). Decline in hand bone mineral density indicates increased risk for erosive change in early rheumatoid arthritis (RA). Poster session presented at the meeting of Abstracts for the RACP Future Directions in Health Congress 2012, as published in Internal Medicine Journal. Brisbane, Qld.: Wiley-Blackwell.
    DOI
    2012 Basnayake, S., Proudman, S., Spargo, L., Hall, C., McWilliams, L., Lee, A., . . . James, M. (2012). Smoking is associated with poorer reponse to 'treat to target' DMARD therapy and fish oil in RA. Poster session presented at the meeting of Internal Medicine Journal. Canberra, NSW: Wiley-Blackwell.
    DOI
    2012 Proudman, S., Spargo, L., Hall, C., McWilliams, L., Lee, A., Rischmueller, M., . . . Cleland, L. G. (2012). Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose. Poster session presented at the meeting of Abstracts of the 2012 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Washington, D.C.: Wiley-Blackwell.
    DOI
    2012 Proudman, S., Spargo, L., Hall, C., McWilliams, L., Lee, A., Rischmueller, M., . . . Cleland, L. (2012). Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI WoS5
    2012 Moore, O., Goh, N., Corte, T., Rouse, H., Hennessy, O., Thakkar, V., . . . Nikpour, M. (2012). Extent of disease on high-resolution CT lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI WoS1
    2012 Thakkar, V., Patterson, K., Stevens, W., Byron, J., Moore, O., Roddy, J., . . . Nikpour, M. (2012). Serum ICAM-1 levels are related to the presence of interstitial lung disease in SSc. Poster session presented at the meeting of Abstracts of the 2nd Systemic Sclerosis World Congress, as published in Rheumatology. Madrid, Spain: Oxford University Press (OUP).
    DOI
    2012 Thakkar, V., Patterson, K., Stevens, W., Byron, J., Moore, O., Roddy, J., . . . Hissaria, P. (2012). Novel biomarkers of dysregulated angiogenesis are not specific to pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI
    2012 Stevens, W., Thakkar, V., Moore, O., Byron, J., Proudman, S., Zochling, J., . . . Nikpour, M. (2012). Lung disease is the major cause of death in the Australian SSc cohort study. Poster session presented at the meeting of Abstracts of the 2nd Systemic Sclerosis World Congress, as published in Rheumatology. Madrid, Spain: Oxford University Press (OUP).
    DOI WoS1
    2012 Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Patterson, K., . . . Nikpour, M. (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI WoS1
    2012 Thakkar, V., Stevens, W., Prior, D., Byron, J., Patterson, K., Hissaria, P., . . . Nikpour, M. (2012). N-terminal pro-brain natriuretic peptide levels predict incident pulmonary arterial hypertension in SSc. Poster session presented at the meeting of Abstracts of the 2nd Systemic Sclerosis World Congress, as published in Rheumatology. Madrid, Spain: Oxford University Press (OUP).
    DOI WoS2
    2012 Tan, J., Patterson, K., Proudman, S., Hakendorf, P., Roberts-Thomson, P., & Walker, J. (2012). Prevalence and clinical phenotypic associations of anti-Ro52/TRIM21 in an Australian scleroderma cohort. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI
    2012 Morrisroe, K., Stevens, W., Byron, J., Thakkar, V., Moore, O., Proudman, S., & Nikpour, M. (2012). Prevalence and correlates of antiphospholipid antibodies in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI
    2012 Thakkar, V., Patterson, K., Stevens, W., Byron, J., Moore, O., Roddy, J., . . . Nikpour, M. (2012). Serum ICAM-1 levels are related to the presence of interstitial lung disease in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI
    2012 Thakkar, V., Patterson, K., Stevens, W., Byron, J., Moore, O., Roddy, J., . . . Hissaria, P. (2012). Novel biomarkers of dysregulated angiogenesis are not specific to pulmonary arterial hypertension in SSc. Poster session presented at the meeting of Abstracts of the 2nd Systemic Sclerosis World Congress, as published in Rheumatology. Madrid, Spain: Oxford University Press (OUP).
    DOI
    2012 Charlesworth, J., Stankovich, J., Lewis, P., Byron, J., Stevens, W., Sahhar, J., . . . Zochling, J. (2012). An immunochip-based interrogation of scleroderma susceptibility variants. Poster session presented at the meeting of Abstracts of the 2nd Systemic Sclerosis World Congress, as published in Rheumatology. Madrid, Spain: Oxford University Press (OUP).
    DOI
    2012 Moore, O., Goh, N., Corte, T., Rouse, H., Hennessy, O., Byron, J., . . . Nikpour, M. (2012). Identifying and quantifying prognostic factors in SSc-related interstitial lung disease using a time-varying covariate survival model. Poster session presented at the meeting of Abstracts of the 2nd Systemic Sclerosis World Congress, as published in Rheumatology. Madrid, Spain: Oxford University Press (OUP).
    DOI
    2012 Graf, S., Lester, S., Nossent, H., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case control study and meta-analysis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI
    2012 Moore, O., Goh, N., Corte, T., Rouse, H., Hennessy, O., Byron, J., . . . Nikpour, M. (2012). Extent of lung disease on high-resolution CT lung is a predictor of mortality in SSc-related interstitial lung disease. Poster session presented at the meeting of Abstracts of the 2nd Systemic Sclerosis World Congress, as published in Rheumatology. Madrid, Spain: Oxford University Press (OUP).
    DOI
    2012 Charlesworth, J., Stankovich, J., Lewis, P., Byron, J., Stevens, W., Sahhar, J., . . . Zochling, J. (2012). An immunochip based interrogation of scleroderma susceptibility variants. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell.
    DOI
    2011 Stevens, W., Nikpour, M., Byron, J., Roddy, J., Sahhar, J., Zochling, J., . . . Proudman, S. (2011). FREQUENCY, CLINICAL CHARACTERISTICS AND RISK FACTORS FOR DIGITAL ULCERS IN SYSTEMIC SCLEROSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    WoS3
    2011 Ngian, G., Sahhar, J., Byron, J., Proudman, S., Hill, C., Roddy, J., . . . Van Doornum, S. (2011). PREVALENCE OF CORONARY HEART DISEASE IN A COHORT OF AUSTRALIAN SCLERODERMA PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2011 Jayaweera, S., Sahhar, J., Englert, H., Proudman, S., Hill, C., & Youssef, P. (2011). MYCOPHENOLATE MOFETIL (MMF) IN SCLERODERMA (SSc) ASSOCIATED INTERSTITIAL LUNG DISEASE (ILD) AND SKIN DISEASE - THE AUSTRALIAN EXPERIENCE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    WoS1
    2011 Black, R., Spargo, L., Schultz, C., Chatterton, B., James, M., Cleland, L., . . . Proudman, S. (2011). Decline in hand bone mineral density indicates increased risk for erosive change in early rheumatoid arthritis (RA). Poster session presented at the meeting of Abstracts of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 52nd Annual Scientific Meeting, as published in Internal Medicine Journal. Brisbane, Qld.: Wiley.
    DOI
Grants and Funding
2009-2012 Identification of microRNAs in Scleroderma. Goodall Y, Goodall G, Proudman S, Hissaria P NHMRC Project Grant ID 626945 $138 500 p.a.
2010-2013 Unrestricted educational grant, Actelion Australia Proudman S, Stevens W, Roddy J, Youssef P, Gabbay E. Australian Scleroderma Interest Group $450 000
2011 Therapeutic drug monitoring of leflunomide Wiese M, Proudman S, O’Doherty, James M, Cleland L Arthritis Australia Barbara Cameron Memorial Grant $15 000
2011 A novel screening biomarker in screening for PAH in SSc Stevens W, Proudman S, Nikpour M. Arthritis Australia project grant $20 000
2011 SSc serum microenvironment dysregulates endothelial progenitor cell migration and tubulogenic ability and contributes to vasculopathy Hissaria P, Bonder C, Proudman S, Patterson K. Arthritis Australia grant-in-aid $20 000
2011-2014 How are periodontal disease and rheumatoid arthritis inter-related? Bartold M, Smith M, Haynes D, Proudman SM App. No. 023747 NHMRC $544,261.00
2013 Therapeutic drug monitoring in intensive therapy for rheumatoid arthritis using methotrexate loading Proudman SM, Wiese M Royal Adelaide Hospital Research Foundation $35 000
2014 Identification of factors that influence efficacy and toxicity with leflunomide in the treatment of rheumatoid arthritis Wiese M, Proudman SM, Shanahan M Arthritis Australia Grant in Aid $14, 000
2014-2016 A Clinical Trial of Anticoagulation in Scleroderma Heart-Lung Disease Nikpour M, Buchbinder R, Prior D, Nandurkar H, Williams T, Gabbay E, Proudman S, Nash P, Zochling J, Stevens W. NHMRC APP1062638 $ 1,139,571
2015 The effect of biological agent treatment of rheumatoid arthritis on periodontal disease. Proudman S, Bartold M RAH Research Fund $35 000
2015 VCAM1 as a therapeutic target in scleroderma Brown M, Kenna T, Proudman S, Stevens W, Nikpour M Arthritis Australia PG422015 $25 000
2016 Intracellular Disease Modifying Antirheumatic Drug Concentrations in Patients with Rheumatoid Arthritis Proudman S, Moghaddami M, Wiese M Royal Adelaide Hospital Research Foundation $49 118

  

Teaching

I contribute to undergraduate teaching for the University of Adelaide School of Medicine, with lectures in years 2 and 4 and clinical skills workshops in years 3 and 4. I am the coordinator of the Rheumatology component of the 4th Year Medical Student musculoskeletal teaching programme. I have been involved in year 4, 5 and 6 clinical examinations and setting and marking exam questions.

Postgraduate teaching includes tutorials, short case rounds, long cases and trial examinations for basic physician trainees and supervision of advanced trainees in rheumatology (clinical and research). I have been the advanced training supervisor for more than 15 advanced trainees, and supervised many of these in research projects which have resulted in presentations and awards  at national or international meetings and publications. I have supervised two vacation students, one Honours student and three PhD students.

I have examined one Master of Philosophy Thesis (The RAGE glycine 82 serine polymorphism and cardiovascular disease in rheumatoid arthritis, L Carroll, The University of Queensland Student Number 33160957) and one PhD, Monash University 2012.

I have examined for the Australian Medical Council and I am on the National Examination Panel for the Royal Australasian College of Physicians Membership exams.

    Expand

  • Current Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2021 Co-Supervisor Outcomes of proximal humerus fractures in children Master of Philosophy (Surgery) Master Part Time Mr Samuel Richard Abbot
    2021 Co-Supervisor Deep learning for the discovery of clinically relevant imaging biomarkers in the assessment of rheumatoid arthritis Doctor of Philosophy Doctorate Full Time Ms Alix Bird
    2020 Co-Supervisor Cardiopulmonary exercise testing for screening of pulmonary hypertension in a clinical population of Scleroderma patients. Doctor of Philosophy Doctorate Part Time Mrs Sarah Ann Madigan
    2017 Co-Supervisor Optimising Therapy in Anca-Associated Vasculitis Doctor of Philosophy Doctorate Full Time Dr Joanna Tieu

  • Past Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2005 - 2010 Co-Supervisor Knowledge Engineering Complex Decision Support System in Managing Rheumatoid Arthritis Doctor of Philosophy Doctorate Full Time Ms Ning Pan
    2002 - 2008 Co-Supervisor Applications of Real Time Musculoskeletal Ultrasonography in Rheumatology Practice Doctor of Philosophy Doctorate Full Time Dr Anita Lee

  • Other Supervision Activities
    Date Role Research Topic Location Program Supervision Type Student Load Student Name
    2012 - 2015 External Supervisor OPTIMISING REMISSION AND TREATMENT OUTCOMES IN RHEUMATOID ARTHRITIS Flinders University Doctor of Philosophy Doctorate Part Time Mihir Wechalekar
    Expand

  • Committee Memberships
    Date Role Committee Institution Country
    2016 - ongoing Member Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis working group — —
    2015 - ongoing Member Systemic Sclerosis 4th World Congress Scientific Committee — —
    2014 - ongoing Member Medical Director Arthritis Australia — —
    2014 - ongoing Founder The Australian New Zealand Musculoskeletal Clinical Trials Group (ANZMusc) — —
    2014 - ongoing Chair Australian Clinical Excellence Program Steering Committee — —
    2013 - ongoing Member National Examiners Panel, Royal College of Physicians — —
    2012 - ongoing Member Scleroderma Clinical Trials Consortium Damage Index working group — —
    2011 - ongoing Member Pulmonary Hypertension Society ANZ Steering Committee — —
    2011 - ongoing Member RAH Research Grants Committee — —
    2011 - 2014 Member RAH Outpatient Clinical Leadership Group — —
    2010 - ongoing Member Arthritis Australia Grant Review Committee — —
    2010 - ongoing Member Australian Clinical Excellence Program Steering Committee — —
    2009 - 2014 Member The Connective Tissue Disease associated Interstitial Lung Disease (CTD-ILD) working group of Outcome Measures in Rheumatology (OMERACT) — —
    2006 - ongoing Member Pulmonary Interstitial Vascular, Orphan transplantation (PIVOT) committee Australian Lung Foundation —
    2006 - ongoing Chair Australian Scleroderma Interest Group — —
    1998 - ongoing Member Med IV Musculoskeletal Clinical Sciences Committee — —

  • Memberships
    Date Role Membership Country
    2013 - ongoing Member American College of Rheumatology —
    2009 - ongoing Member Scleroderma Clinical Trials Consortium —
    2009 - ongoing Member South Australian Salaried Medical Officers Association —
    1997 - ongoing Member Australian Rheumatology Association —

  • Consulting/Advisories
    Date Institution Department Organisation Type Country
    2008 - 2014 ARA Arthritis Research Trust Scientific Advisory Board — — —
Connect With Me
External Profiles